<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/152405</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;152405</article-id><article-id pub-id-type="other" hwp:sub-type="slug">152405</article-id><article-id pub-id-type="other" hwp:sub-type="tag">152405</article-id><article-version>1.2</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Cancer Biology" hwp:journal="biorxiv"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin against metastases in breast cancer</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>*</label>Corresponding author E-mail: <email hwp:id="email-1">kmw@rockefeller.edu</email> (KMW)</corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" corresp="yes" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9231-1986</contrib-id><name name-style="western" hwp:sortable="Wittkowski Knut M."><surname>Wittkowski</surname><given-names>Knut M.</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-9231-1986"/></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="Dadurian Christina"><surname>Dadurian</surname><given-names>Christina</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6504-9927</contrib-id><name name-style="western" hwp:sortable="Kim Han Sang"><surname>Kim</surname><given-names>Han Sang</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-6504-9927"/></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Hoshino Ayuko"><surname>Hoshino</surname><given-names>Ayuko</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0193-4131</contrib-id><name name-style="western" hwp:sortable="Lyden David"><surname>Lyden</surname><given-names>David</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-3" hwp:rel-id="aff-2">2</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0003-0193-4131"/></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2">
<label>1</label><institution hwp:id="institution-1">Center for Clinical and Translational Science, The Rockefeller University</institution>, New York, New York, <country>United States of America</country>.</aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2 xref-aff-2-3">
<label>2</label><institution hwp:id="institution-2">Department of Pediatrics, and Cell and Developmental Biology Weill Medical College of Cornell University</institution>, New York, New York, <country>United States of America</country>
</aff></contrib-group><pub-date pub-type="epub-original" hwp:start="2017"><year>2017</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2017-06-20T10:26:59-07:00">
    <day>20</day><month>6</month><year>2017</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2017-08-16T19:36:53-07:00">
    <day>16</day><month>8</month><year>2017</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2017-06-20T10:43:50-07:00">
    <day>20</day><month>6</month><year>2017</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2017-08-16T20:03:54-07:00">
    <day>16</day><month>8</month><year>2017</year>
  </pub-date><elocation-id>152405</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2017-06-19"><day>19</day><month>6</month><year>2017</year></date>
<date date-type="rev-recd" hwp:start="2017-08-16"><day>16</day><month>8</month><year>2017</year></date>
<date date-type="accepted" hwp:start="2017-08-16"><day>16</day><month>8</month><year>2017</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2017, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2017</copyright-year><license hwp:id="license-1"><p hwp:id="p-1">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="152405.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/152405v2.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="152405.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/152405v2/152405v2.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/152405v2/152405v2.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-2">Most breast cancer deaths are caused by metastasis and treatment options beyond radiation and cytotoxic drugs are urgently needed. This study reanalyzed existing data from three genome-wide association studies (GWAS) using a novel computational biostatistics approach (muGWAS), which had been validated in studies of 600–2000 subjects in epilepsy and autism. MuGWAS jointly analyzes several neighboring single nucleotide polymorphisms while incorporating knowledge about genetics of heritable diseases into the statistical method and about GWAS into the rules for determining adaptive genome-wide significance.</p><p hwp:id="p-3">Results from three independent GWAS of 1000–2000 subjects each, which were made available under the National Institute of Health’s “Up For A Challenge” (U4C) project, not only confirmed cell-cycle control and receptor/AKT signaling, but, for the first time in breast cancer GWAS, also consistently identified many endo-/exocytosis (EEC) genes, most of which had already been observed in functional and expression studies of breast cancer. In particular, the findings include genes that translocate (<italic toggle="yes">ATP8A1</italic>, <italic toggle="yes">ATP8B1, ANO4, ABCA1</italic>) and metabolize (<italic toggle="yes">AGPAT3</italic>, <italic toggle="yes">AGPAT4</italic>, <italic toggle="yes">DGKQ</italic>, <italic toggle="yes">LPPR1</italic>) phospholipids entering the phosphatidylinositol cycle, which controls EEC. These novel findings suggest scavenging phospholipids via alpha-cyclodextrin (αCD) as a novel intervention to control packaging of exosomes (which prepare distant microenvironment for organ-specific metastases) and endocytosis of β1 integrins (which are required for spread of metastatic phenotype and mesenchymal migration of tumor cells).</p><p hwp:id="p-4">Beta-cyclodextrin (βCD) had already been shown to be effective in <italic toggle="yes">in vitro</italic> and animal studies of breast cancer, but exhibits cholesterol-related ototoxicity. The smaller αCD also scavenges phospholipids, but cannot fit cholesterol. An <italic toggle="yes">in-vitro</italic> study presented here confirms hydroxypropyl (HP)-αCD to be twice as effective as HPβCD against migration of human cells of both receptor negative and estrogen-receptor positive breast cancer.</p><p hwp:id="p-5">If the previous successful animal studies with βCDs are replicated with the safer and more effective αCDs, clinical trials of αCDs are warranted in women with triple-negative breast cancer, who have few treatment options and poor prognosis.</p></abstract><counts><page-count count="26"/></counts><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-1">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta></front><body><sec id="s1" hwp:id="sec-1"><title hwp:id="title-2">Introduction</title><p hwp:id="p-6">Breast cancer is the most common cancer in women worldwide.<sup>(<xref rid="c112" ref-type="bibr" hwp:id="xref-ref-112-1" hwp:rel-id="ref-112">Rojas 2016</xref>)</sup> In 2016, 246,660 new U.S. cases were estimated.<sup>(<xref rid="c119" ref-type="bibr" hwp:id="xref-ref-119-1" hwp:rel-id="ref-119">Siegel 2016</xref>)</sup> The highly penetrant, but rare mutations in <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> point to DNA repair deficiencies as an etiological factor, but explain only 5 to 10 percent of cases. Patients with breast cancer positive for estrogen receptor (ER) or human epidermal growth factor (GF) receptor type 2 (<italic toggle="yes">HER2</italic>) initially respond well to anti-estrogen or anti-HER2 therapy, respectively, but inevitably become refractory.<sup>(<xref rid="c54" ref-type="bibr" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">Hayashi 2015</xref>)</sup> Triple-negative breast cancer, which additionally lacks expression of progesterone receptor (PR), harbors an aggressive clinical phenotype with limited treatment options.</p><p hwp:id="p-7">As of May, 2016, the deadline for participation in the National Cancer Institutes’ “Up For A Challenge” (U4C) breast cancer challenge, 127 single nucleotide polymorphisms (SNPs) had been associated with breast cancer in women of European ancestry <sup>(<xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">Burdett</xref>)</sup> at the conventional fixed <italic toggle="yes">s</italic> = -log(<italic toggle="yes">p</italic>) = 7.3 level for genome-wide statistical significance (GWS) <sup>(<xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">Barsh 2012</xref>)</sup> (<italic toggle="yes">s</italic> is used throughout for significance). These SNPs map to 51 genes with known function; all but 16 involved in three known pathways: 27 are associated with nuclear function (DNA repair, transcription, cellcycle control), six with receptor signaling, ion channels, and mammary gland development (KEGG pathway hsa04915) and two with AKT signaling (hsa04064).<sup>(<xref rid="c66" ref-type="bibr" hwp:id="xref-ref-66-1" hwp:rel-id="ref-66">Kendellen 2014</xref>)</sup> The U4C aimed to generate novel testable biological hypotheses (80 FR 32168).</p><p hwp:id="p-8">The present evaluation is based on separate analyses of three independent populations of women of European ancestry (see Subjects). Two of the populations (EPIC, PBCS) had never been analyzed individually, because their sample size was deemed insufficient for conventional statistical approaches.</p><p hwp:id="p-9">Most breast cancer deaths are not due to the primary tumor, but to metastases, often in the bone, lung, liver, and brain. The genetics results submitted under the U4C implicate dysregulation and dysfunction of endo-/exocytosis (EEC), which is involved in cell migration and invasion, as well as organ targeting, and, thus, suggest overall downregulation of phosphoinositides (PI) as a novel treatment strategy against metastases. The hypothesis that alpha-cyclodextrin (αCD), which scavenges phospholipids, is effective in reducing migration of breast cancer tumor cells was subsequently confirmed in an <italic toggle="yes">in vitro</italic> study. Taken together, the results suggest (derivatives of) αCD as a potential treatment to prevent metastases in carcinomas without the side effects of radiation and cytotoxic therapies.</p></sec><sec id="s2" hwp:id="sec-2"><title hwp:id="title-3">Materials and Methods</title><sec id="s2a" hwp:id="sec-3"><title hwp:id="title-4">Ethics Statement</title><p hwp:id="p-10">The study was approved by The Rockefeller University IRB on Aug 24, 2015 (ref# 330390, exempt).</p></sec><sec id="s2b" hwp:id="sec-4"><title hwp:id="title-5">Subjects</title><p hwp:id="p-11">This reanalysis is based on data from three GWAS in women of European ancestry:
<list list-type="simple" hwp:id="list-1"><list-item hwp:id="list-item-1"><label>(a)</label><p hwp:id="p-12">the NHS cases from the Nurses’ Health Study as part of the Cancer Genetic Markers project (CGEM, phs000147/39389-2/GRU, 1145 cases / 1142 controls), <sup>(<xref rid="c59" ref-type="bibr" hwp:id="xref-ref-59-1" hwp:rel-id="ref-59">Hunter 2007</xref>; <xref rid="c47" ref-type="bibr" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">Haiman 2011</xref>)</sup></p></list-item><list-item hwp:id="list-item-2"><label>(b)</label><p hwp:id="p-13">ER<sup>-</sup> cases from the nested case-control study of the European Prospective Investigation into Cancer (EPIC, phs000812/39395-2/HMB-PU, 511 cases / 500 controls),<sup>(<xref rid="c118" ref-type="bibr" hwp:id="xref-ref-118-1" hwp:rel-id="ref-118">Siddiq 2012</xref>)</sup></p></list-item><list-item hwp:id="list-item-3"><label>(c)</label><p hwp:id="p-14">ER<sup>-</sup> cases from the Polish Breast Cancer Case-Control Study (PBCS, phs000812/39397-2, 543 cases / 511 controls),<sup>(<xref rid="c118" ref-type="bibr" hwp:id="xref-ref-118-2" hwp:rel-id="ref-118">Siddiq 2012</xref>)</sup></p></list-item></list></p><p hwp:id="p-15">The EPIC and PBCS studies are part of the Breast and Prostate Cancer Cohort Consortium GWAS (BPC3), which was supported by the National Cancer Institute (NCI) under cooperative agreements U01-CA98233, U01-CA98710, U01-CA98216, and U01-CA98758 and the Intramural Research Program of the NCI, Division of Cancer Epidemiology and Genetics (see <ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.synapse.org/#!Synapse:syn3157598/wiki/232630" ext-link-type="uri" xlink:href="https://www.synapse.org/#!Synapse:syn3157598/wiki/232630" hwp:id="ext-link-1">https://www.synapse.org/#!Synapse:syn3157598/wiki/232630</ext-link> for further details).</p></sec><sec id="s2c" hwp:id="sec-5"><title hwp:id="title-6">Statistical Methods</title><p hwp:id="p-16">In this analysis, conventional single-SNP GWAS (ssGWAS) are complemented with a computational biostatistics approach (muGWAS, GWAS using muStat <sup>(<xref rid="c141" ref-type="bibr" hwp:id="xref-ref-141-1" hwp:rel-id="ref-141">Wittkowski 2012</xref>)</sup>) that incorporates knowledge about genetics into the method <sup>(<xref rid="c140" ref-type="bibr" hwp:id="xref-ref-140-1" hwp:rel-id="ref-140">Wittkowski 2010</xref>, Sections 4.3.4 and 4.4.2; <xref rid="c139" ref-type="bibr" hwp:id="xref-ref-139-1" hwp:rel-id="ref-139">Wittkowski 2013</xref>)</sup> and knowledge about the nature of GWAS into the decision strategy.<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-1" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup></p><p hwp:id="p-17">Statistical methods tend to have higher power if they are based on more realistic assumptions, which, in biology, tend to be weak. In contrast, methods based on stronger assumptions, such as additivity of allelic effects and independence of SNPs within an linkage disequilibrium (LD) block (LDB), may generate more significant results when errors happen to fulfill these assumptions than for true effects. With millions of test statistics calculated, even a rare false positive result due to model-misspecification (1/10,000 tests, say), may result in the 100 most significant results all being false positives. U-statistics for multivariate data in GWAS (muGWAS) rely only on weak, realistic assumptions, but require large amounts of memory and GPU enabled cloud instances, which became available only after 2001 and 2009, respectively.</p><p hwp:id="p-18">After excluding non-informative or low-quality SNPs and SNPs in high LD with an immediate neighbor <sup>(<xref rid="c61" ref-type="bibr" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">Ioannidis 2009</xref>)</sup> (20–25%) to avoid loss of power when including irrelevant SNPs <sup>(<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-1" hwp:rel-id="ref-74">Li 2012</xref>)</sup>, an initial traditional ssGWAS was performed, using the u-test for univariate data.<sup>(<xref rid="c85" ref-type="bibr" hwp:id="xref-ref-85-1" hwp:rel-id="ref-85">Mann 1947</xref>; <xref ref-type="bibr" rid="c136" hwp:id="xref-ref-136-1" hwp:rel-id="ref-136">Wilcoxon 1954</xref>; <xref ref-type="bibr" rid="c70" hwp:id="xref-ref-70-1" hwp:rel-id="ref-70">Kruskal 1957</xref>)</sup> The same data was then analyzed using a u-test for genetically structured multivariate data.<sup>(<xref rid="c139" ref-type="bibr" hwp:id="xref-ref-139-2" hwp:rel-id="ref-139">Wittkowski 2013</xref>)</sup> U-statistics avoid model-misspecification biases by replacing linear/logistic <sup>(<xref ref-type="bibr" rid="c143" hwp:id="xref-ref-143-1" hwp:rel-id="ref-143">Wu 2010b</xref>)</sup> with non-parametric kernels.<sup>(<xref ref-type="bibr" rid="c74" hwp:id="xref-ref-74-2" hwp:rel-id="ref-74">Li 2012</xref>)</sup></p><p hwp:id="p-19">Below, we describe the assumptions about genetics and GWAS that are implemented in the statistical method and decision strategy and refer to published empirical validation of this approach.</p><sec id="s2c1" hwp:id="sec-6"><label>1.1</label><title hwp:id="title-7">Heterodominance</title><p hwp:id="p-20">A particular SNP is not assumed to be either recessive (aA = aa), additive (aA = (aa+AA)/2), or dominant (aA = AA), but merely monotonic (aa &lt; aA &lt; AA). Accordingly, the information contributed by a particular SNP is represented as a matrix detailing for each of the <italic toggle="yes">n</italic>×<italic toggle="yes">n</italic> pairs of <italic toggle="yes">n</italic> subjects whether the genetic risk carried by the row subject is lower “&lt; ”, the same “=”, or higher “&gt;” than the risk of column subject, or unknown (“ ”) in case of missing data in one or both of the subjects. Below, the possible genetic risk constellations (left) are compared to models with different degrees of dominance (right). While the left matrix is similar to the matrix for dominant effects (all non-zero elements are ±2), the (logical) inequalities are not (numerically) equivalent. In effect, the single-SNP results based on the adaptive u-scores for aa, aA, and AA are similar to results from the Cochran-Armitage test for additive co-dominance, <sup>(<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">Cochran 1954</xref>; <xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">Armitage 1955</xref>)</sup> which uses fixed scores 0, 1, and 2.</p><fig id="utbl1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/UTBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">utbl1</object-id><graphic xlink:href="152405_utbl1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig></sec><sec id="s2c2" hwp:id="sec-7"><label>1.2</label><title hwp:id="title-8">LD-structure</title><p hwp:id="p-21">A basic assumption underlying GWAS, in general, is that a disease locus should be in LD with both neighboring SNPs (unless they are separated by a recombination hotspot). Hence, the information from two neighboring SNPs is not numerically ADD-ed, but logically AND-ed using the function ∧</p><fig id="utbl2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/UTBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">utbl2</object-id><graphic xlink:href="152405_utbl2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><p hwp:id="p-22">As muStat allows variables to be correlated, other SNPs within an LDB may be in LD, too, yet there is no formal representation of more distant LD. Non-informative SNPs added between LDBs prevent intervals from spanning LDBs.</p></sec><sec id="s2c3" hwp:id="sec-8"><label>1.3</label><title hwp:id="title-9">Cis-epistasis, including compound-heterozygosity</title><p hwp:id="p-23">To account for interactions between functional polymorphisms,<sup>(<xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">Aslibekyan 2013a</xref>)</sup> a natural extension of ∧ is then used to combine information from corresponding elements of the <italic toggle="yes">n</italic>×<italic toggle="yes">n</italic> matrices containing information about neighboring pairs. Assuming, without loss of generality, the case of only four SNPs within in the same LDB, the aggregated diplotype information for one pair of subjects is
<disp-formula id="ueqn1" hwp:id="disp-formula-1">
<alternatives hwp:id="alternatives-1"><graphic xlink:href="152405_ueqn1.gif" position="float" orientation="portrait" hwp:id="graphic-3"/></alternatives>
</disp-formula>
which can be one of the following:</p><fig id="utbl3" position="float" fig-type="figure" orientation="portrait" hwp:id="F3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/UTBL3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">utbl3</object-id><graphic xlink:href="152405_utbl3" position="float" orientation="portrait" hwp:id="graphic-4"/></fig><p hwp:id="p-24">From the above inequality, the results typically differ when SNPs from the same tag sets appear in different permutations, which increases the resolution over methods assuming commutativity.</p></sec><sec id="s2c4" hwp:id="sec-9"><label>1.4</label><title hwp:id="title-10">Test statistic</title><p hwp:id="p-25">From the resulting <italic toggle="yes">n</italic>×<italic toggle="yes">n</italic> matrix W (say), one calculates each subject’s risk score <italic toggle="yes">u</italic><sub><italic toggle="yes">i</italic></sub> (−<italic toggle="yes">n</italic> &lt; <italic toggle="yes">u</italic><sub><italic toggle="yes">i</italic></sub> &lt; <italic toggle="yes">n</italic>) as the number of subjects having lower risk, minus the number of subjects having higher risk, i.e., #(<italic toggle="yes">w</italic><sub><italic toggle="yes">ij</italic></sub> = <italic toggle="yes">“&lt; ”</italic>)<sub>j</sub> - #(<italic toggle="yes">w</italic><sub><italic toggle="yes">ij</italic></sub> = <italic toggle="yes">“&gt;”</italic>)<sub>j</sub>. These scores are then compared between cases and controls using a standard linear score test.<sup>(<xref rid="c48" ref-type="bibr" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">Hajek 1967</xref>)</sup></p></sec><sec id="s2c5" hwp:id="sec-10"><label>1.5</label><title hwp:id="title-11">Regularization</title><p hwp:id="p-26">Since it is unknown <italic toggle="yes">a priori</italic>, whether a minor allele is dangerous, irrelevant, or protective, all combinations of (-1, 0, +1) “polarities” are applied to the SNPs <italic toggle="yes">S</italic><sub><italic toggle="yes">k</italic></sub>, …, <italic toggle="yes">S</italic><sub><italic toggle="yes">k</italic>+3</sub>, resulting in many highly dependent test statistics being calculated for the diplotypes surrounding a given SNP. The test statistic chosen is the one that has the highest u(-log(<italic toggle="yes">p</italic>), <italic toggle="yes">IC</italic>) score, where the information content (IC) is the proportion of pairwise orderings in <italic toggle="yes">W</italic> that can be decided (≠“?”) for a given choice of polarities. This approach avoids over-fitting (highly significant results based on a small subset of unusual subjects) without the need to choose arbitrary regularization cut-offs.<sup>(<xref rid="c38" ref-type="bibr" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">Frommlet 2016</xref>)</sup></p></sec><sec id="s2c6" hwp:id="sec-11"><label>2.1</label><title hwp:id="title-12">Adaptive genome-wide significance</title><p hwp:id="p-27">The traditional p-value cut-off of <italic toggle="yes">s</italic> = 7.3 for GWS has been widely criticized as overly conservative,<sup>(<xref rid="c99" ref-type="bibr" hwp:id="xref-ref-99-1" hwp:rel-id="ref-99">Pearson 2008</xref>; <xref rid="c98" ref-type="bibr" hwp:id="xref-ref-98-1" hwp:rel-id="ref-98">Panagiotou 2012</xref>)</sup> yet few alternatives have been formally derived. Here, we replace a fixed cut-off for GWS with an empirical <sup>(<xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-2" hwp:rel-id="ref-4">Aslibekyan 2013a</xref>)</sup> adaptive (study-specific) cut-off (aGWS) that automatically accounts for the specifics of the population studied, the chip used, differences in minor allele frequency (MAF,) and GWAS being non-randomized.<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-2" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup> As previously discussed,<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-3" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup> the expected distribution in a ssGWAS QR plot is a mixture of univariate distributions whose carriers vary by MAF, because the most significant result possible depends on MAF when outcomes are bounded (allele counts 0, 1, 2). Hence, it is a convex curve, rather than a straight line;<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-4" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup> see, for instance, CGEM chromosomes 14–17, 19, and 22 (S1 Fig 2). In a whole genome (WG) plot, this curvature may not be apparent (see <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-4-1" hwp:rel-id="F4">Fig 1</xref>), when some chromosomes’ QR curves are concave because of true association, which is expected in a familial disease or with systematic unrelated differences between non-randomized populations. Hence, an apparently straight line in a WG plot may be due to concave curves in chromosomes with true positives and convex curves in others canceling each other out. With muGWAS, where many dependent tests are performed at overlapping window positions, the expected QR curve (see S1 Fig 3) may be even more convex. The expected distribution curve is estimated from the 50% of chromosomes with the fewest outliers rising above a convex fit.<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-5" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup> The empirical adaptive (study-specific) aGWS cutoff is the median apex (highest point) of a convex curve fitted against these chromosomes’ QR plot.</p><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F4" hwp:rev-id="xref-fig-4-1 xref-fig-4-2 xref-fig-4-3 xref-fig-4-4 xref-fig-4-5 xref-fig-4-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F4</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig 1:</label><caption hwp:id="caption-1"><title hwp:id="title-13">GWAS Quantile-Rank (QR) plots.</title><p hwp:id="p-28">Left: ssGWAS, right: muGWAS (each point represents the most significant result among all diplotypes centered at the same SNP) Results are ranked by significance (bottom). For the most significant results and other results of interest, the location of SNPs to genes is shown in S1 Fig 5. Upper curve (red): convex fit against points; dashed extension: projection; lower curve (blue): population-specific expectation. Vertical lines between curves connect the highest <italic toggle="yes">s</italic>-values (-log<sub>10</sub> <italic toggle="yes">p</italic>) of a gene (dot) with its expected value for genes with known function. Light gray vertical lines indicate genes omitted from the list because of low reliability (either low µIC or reliance on a single SNP), respectively. Genes to the right of the vertical dark line are above the aGWS cut-off. See S1 Fig 1 for Manhattan plots. The horizontal solid line at highest point at the end of the expected curve indicates the estimate for adjusted GWS (aGWS). All points above the horizontal line (and genes to the right of the vertical blue line) are “significant” at the aGWS level.</p></caption><graphic xlink:href="152405_fig1" position="float" orientation="portrait" hwp:id="graphic-5"/></fig></sec><sec id="s2c7" hwp:id="sec-12"><label>2.2.</label><title hwp:id="title-14">Replication</title><p hwp:id="p-29">Complex diseases may involve different SNPs in high LD with causal variants across populations,<sup>(<xref rid="c103" ref-type="bibr" hwp:id="xref-ref-103-1" hwp:rel-id="ref-103">Pickrell 2016</xref>)</sup> epistasis between several SNPs per locus, several loci per gene, and several genes per function, with risk factors differing across populations (see above). Hence, we will consider SNPs within a locus, loci within a gene, and genes with a direct mechanistic relationship (paralogs, binding partners, …) for replication. <sup>(<xref rid="c102" ref-type="bibr" hwp:id="xref-ref-102-1" hwp:rel-id="ref-102">Peng 2010</xref>; <xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-3" hwp:rel-id="ref-4">Aslibekyan 2013a</xref>)</sup> Results are considered “replicated” if supportive results are significant at the aGWS/2 level.</p><p hwp:id="p-30"><bold>Validation:</bold> The above approaches have been validated in two published analyses, where previous analyses using ssGWAS and fixed GWS also had identified not more than a few apparently unrelated SNPs.
<list list-type="bullet" hwp:id="list-2"><list-item hwp:id="list-item-4"><p hwp:id="p-31">In epilepsy,<sup>(<xref rid="c139" ref-type="bibr" hwp:id="xref-ref-139-3" hwp:rel-id="ref-139">Wittkowski 2013</xref>)</sup> muGWAS confirmed the Ras pathway and known drug targets (ion channels, <italic toggle="yes">IL1B</italic>). In that analysis, muGWAS was also compared with a parametric analogue, logistic regression with interaction terms for neighboring SNPs (lrGWAS). muGWAS produced fewer apparent false positives (isolated highly significant results far away from coding regions) <sup>(Wittkowski 201, Suppl. Fig 2)</sup> and higher sensitivity for genes downstream of Ras, which are involved in more complex cis-epistatic interactions,<sup>(Wittkowski 2013, <xref ref-type="fig" rid="fig3" hwp:id="xref-fig-6-1" hwp:rel-id="F6">Fig 3</xref>, blue)</sup> than ion channels, which were also implicated by lrGWAS.<sup>(Wittkowski 2013, <xref ref-type="fig" rid="fig3" hwp:id="xref-fig-6-2" hwp:rel-id="F6">Fig 3</xref>, red)</sup></p></list-item><list-item hwp:id="list-item-5"><p hwp:id="p-32">In autism,<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-6" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup> muGWAS identified sets of mechanistically related genetic risk factors for mutism in autism (independently confirmed in functional studies <sup>(<xref rid="c45" ref-type="bibr" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">Guglielmi 2015</xref>)</sup> and a pathway network analysis <sup>(<xref rid="c135" ref-type="bibr" hwp:id="xref-ref-135-1" hwp:rel-id="ref-135">Wen 2016</xref>)</sup>). In,<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-7" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup>, adaptive GWS was validated against three analyses with randomly permutated phenotypes. Only one gene (DMD, not aGWS) appeared in one of the other analyses (also not aGWS). Moreover, there is no noticeable overlap between aGWS genes between breast cancer and either mutism <sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-8" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup> or epilepsy <sup>(Wittkowski 2014, Suppl. Fig 7)</sup>, while there is considerable functional overlap between mutism in autism and epilepsy, as expected.</p></list-item></list></p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F5" hwp:rev-id="xref-fig-5-1 xref-fig-5-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F5</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig 2:</label><caption hwp:id="caption-2"><title hwp:id="title-15">EEC of β1 Integrin underlying mesenchymal tumor cell migration and invasion.</title><p hwp:id="p-33">Cell migration necessitates trafficking of β1 integrin, whose internalization is controlled by dynamin. Both clathrinand caveolin 1 (CAV1)coated domains of the plasma membrane are involved. Once in early endosomes (EE), integrins may be sorted for degradation in lysosomes, recycled to the plasma membrane through a RAB4-dependent route, or transported to the recycling endosome (RE). Recycling from the RE requires Rab11 family members, such as RAB25 which is often aberrantly expressed in human tumors, including luminal B breast cancer. <sup>(<xref rid="c90" ref-type="bibr" hwp:id="xref-ref-90-1" hwp:rel-id="ref-90">Mitra 2016</xref>)</sup> (adopted from <sup>(<xref rid="c93" ref-type="bibr" hwp:id="xref-ref-93-1" hwp:rel-id="ref-93">Mosesson 2008</xref>; <xref rid="c92" ref-type="bibr" hwp:id="xref-ref-92-1" hwp:rel-id="ref-92">Morgan 2009</xref>; <xref rid="c29" ref-type="bibr" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">De Franceschi 2015</xref>)</sup>)</p></caption><graphic xlink:href="152405_fig2" position="float" orientation="portrait" hwp:id="graphic-6"/></fig><fig id="fig3" position="float" fig-type="figure" orientation="portrait" hwp:id="F6" hwp:rev-id="xref-fig-6-1 xref-fig-6-2 xref-fig-6-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F6</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Fig 3:</label><caption hwp:id="caption-3"><title hwp:id="title-16">Endo-/exocytosis pathway.</title><p hwp:id="p-34">Pink: genes identified in this analysis, most of which have been implicated in breast cancer previously (S1 Table 1), by stage of EEC: Formation of clathrincoated vesicles, E3 ubiquitination, separation of inactive integrin (fast recycling) from active integrins (slow recycling), sorting between secretory, lysosomal, and (slow) recycling pathway, and lysosomal degradation. Red and green genes are known breast cancer promoters and suppressors, respectively (S1 Table 3).</p><p hwp:id="p-35">Clathrin-mediated endocytosis (CME) begins with co-assembly of the heterotetrameric adaptor complex AP-2 with clathrin at PI(4,5)P<sub>2</sub>-rich plasma membrane sites. AP-2 in its open conformation recruits clathrin and additional endocytic proteins, many of which also bind to PI(4,5)P<sub>2</sub>.</p><p hwp:id="p-36">CCP maturation may be accompanied by SHIP-2-mediated dephosphorylation of PI(4,5)P<sub>2</sub> to PI(4)P. Synthesis of PI(3,4)P<sub>2</sub> is required for assembly of the PX-BAR domain protein SNX9 at constricting CCPs and may occur in parallel with PI(4,5)P<sub>2</sub> hydrolysis to PI(4)P via synaptojanin, thereby facilitating auxilindependent vesicle uncoating by the clathrin-dependent recruitment and activation of PI3KC2α, a class II PI3-kinase. PI(3,4)P<sub>2</sub> may finally be converted to PI(3)P en route to endosomes by the 4phosphatases <italic toggle="yes">INPP4A/B</italic>, effectors of the endosomal GTPase Rab5. Adapted from <sup>(<xref rid="c104" ref-type="bibr" hwp:id="xref-ref-104-1" hwp:rel-id="ref-104">Posor 2015</xref>)</sup></p><p hwp:id="p-37">In the early endosome, β1 integrins are sorted. Inactive integrins undergo fast “short loop” recycling; active integrins go to the late endosome / multivesicular body for slow “long group” recycling (<italic toggle="yes">RAB11</italic>), lysosomal degeneration (unless rescued by <italic toggle="yes">RAB25</italic>/<italic toggle="yes">CLIC3</italic>), or secretion via the trans-Golgi-network (TGN) mediated by <italic toggle="yes">RAB9</italic>.</p><p hwp:id="p-38">Fast recycling of epidermal GF receptor drives proliferation,<sup>(<xref rid="c124" ref-type="bibr" hwp:id="xref-ref-124-1" hwp:rel-id="ref-124">Tomas 2014</xref>)</sup> so one would expect gain-of-function mutations in the upper part of the Figure.</p><p hwp:id="p-39">Lysosomal and synaptic vesicle exocytosis share many similarities. Endolysosome-localized PIs may regulate lysosomal trafficking.<sup>(<xref rid="c114" ref-type="bibr" hwp:id="xref-ref-114-1" hwp:rel-id="ref-114">Samie 2014</xref>)</sup></p><p hwp:id="p-40">(derived, in part from KEGG pathways hsa04144 and hsa04721).</p></caption><graphic xlink:href="152405_fig3" position="float" orientation="portrait" hwp:id="graphic-7"/></fig></sec></sec><sec id="s2d" hwp:id="sec-13"><title hwp:id="title-17"><italic toggle="yes">In vitro</italic> Assay</title><p hwp:id="p-41">A 24-well plate (CBA-120, Cell BioLabs Inc., San Diego, CA) with CytoSelect Wound Healing Inserts was warmed up at room temperature for 10 min. A cell suspension used contained 0.5– 1.0 × 10<sup>6</sup> cells/ml in media containing 10% fetal bovine serum (FBS) was prepared and 1 mL of this suspension was added to each well. Cells were then incubated for 12 h, after which time the insert was removed and cells were washed with new media to remove dead cells and debris. FBS with/without CDs (Sigma-Aldridge, St. Louis, MO) was added to start the wound healing process. Cells were incubated for 2 h, washed with PBS, fresh control media was added, and cells were incubated for another 12 h. After removing the fixation solution, 400 µL of Cell Stain Solution were added to each well and incubated for 15 min at room temperature, after which stained wells were washed thrice with deionized water and left to dry at room temperature. Cells that migrated into the wounded area or protruded from the border of the wound were visualized and photographed under an inverted microscope to determine migrated cell surface area.</p><p hwp:id="p-42"><ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.cellbiolabs.com/sites/default/files/CBA-120-wound-healing-assay.pdf" ext-link-type="uri" xlink:href="https://www.cellbiolabs.com/sites/default/files/CBA-120-wound-healing-assay.pdf" hwp:id="ext-link-2">https://www.cellbiolabs.com/sites/default/files/CBA-120-wound-healing-assay.pdf</ext-link></p></sec></sec><sec id="s3" hwp:id="sec-14"><title hwp:id="title-18">Results</title><sec id="s3a" hwp:id="sec-15"><title hwp:id="title-19">Additional ssGWAS CGEM results complement known breast cancer risk factors</title><p hwp:id="p-43">The original CGEM analysis had identified two SNPs (rs1219648: <italic toggle="yes">s</italic> = 5.49, rs2420946: 5.46) in the fibroblast GF receptor <italic toggle="yes">FGFR2</italic> <sup>Entrez</sup> <sup>Gene 2263, (<xref rid="c59" ref-type="bibr" hwp:id="xref-ref-59-2" hwp:rel-id="ref-59">Hunter 2007</xref>)</sup> which affects mammary epithelial cell growth and migration,<sup>(<xref rid="c26" ref-type="bibr" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">Czaplinska 2014</xref>)</sup> and a SNP (rs10510126: 6.25, &gt;1 MB apart from <italic toggle="yes">FGFR2</italic>) subsequently located to a long variant of the mitotic checkpoint protein <italic toggle="yes">BUB3</italic> <sup>9184</sup>. These two genes are also the only genes in the present analysis with SNPs above the diagonal in the summary ssGWAS quantile-rank (QR, often: QQ) plot (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-4-2" hwp:rel-id="F4">Fig 1</xref> left), although the QR plots of several individual chromosomes show association in chromosomes 4 (the <italic toggle="yes">SNCA</italic>–<italic toggle="yes">MMRN1</italic> <sup>22915</sup> region), 5 (breast cancer associated transcript <italic toggle="yes">BRCAT54</italic> <sup>100506674</sup>, non-coding), 6 (<italic toggle="yes">PARK2</italic> <sup>5071</sup>, the Parkinson’s disease [PD] ubiquitin ligase Parkin), and 9 (<italic toggle="yes">LPPR1</italic> <sup>54886</sup>, phospholipid phosphatase-related 1) (S1 Fig 2).</p><p hwp:id="p-44">In the present analysis, a total of 22 genes and <italic toggle="yes">BRCAT49</italic> <sup>(<xref rid="c62" ref-type="bibr" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">Iyer 2015</xref>)</sup> reached aGWS in CGEM (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-4-3" hwp:rel-id="F4">Fig 1</xref>, left, blue). A total of 21, 11, and 24 genes with known function or relation to breast cancer exceeded muGWAS aGWS in CGEM, EPIC, and PBCS, respectively.</p></sec><sec id="s3b" hwp:id="sec-16"><title hwp:id="title-20">Novel ssGWAS aGWS results in EPIC and PBCS complement CGEM results</title><p hwp:id="p-45">In EPIC, the two most significant SNPs (rs4791889: 5.66 and rs9596958: 5.42) are located 4.5 kB upstream of the chromodomain helicase DNA binding protein <italic toggle="yes">CHD3</italic> <sup>1107</sup> and the transcription factor (TF) <italic toggle="yes">SOHLH2</italic> <sup>54937</sup>, respectively (see S1 Table 2 and S1 Fig 5).</p><p hwp:id="p-46">In PBCS, the two most significant SNPs (rs2297075: 5.83, rs943628: 5.55, 100 kB apart) are located in <italic toggle="yes">DOCK8</italic> <sup>81704</sup>, a guanine nucleotide exchange factor for Rac1, which drives mesenchymal cell movement.<sup>(<xref rid="c132" ref-type="bibr" hwp:id="xref-ref-132-1" hwp:rel-id="ref-132">Wang 2015b</xref>)</sup> Significance of <italic toggle="yes">FGFR2</italic> relies on the two previously reported and a third SNP (rs11200014) within intron 2.<sup>(<xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">Cui 2016</xref>)</sup> Significance in <italic toggle="yes">BUB3</italic> is driven by three SNPs in high LD (rs10510126, rs17663978, rs7916600, spanning 30 kB). These findings are consistent with significance of the top five SNPs in ssGWAS depending on a single polymorphism each. Lack of evidence in EPIC and PBCS (S1 Table 2) is consistent with different variations developing in divergent European populations.</p></sec><sec id="s3c" hwp:id="sec-17"><title hwp:id="title-21">muGWAS aGWS results are cross-validated across CGEM, EPIC, and PBCS</title><p hwp:id="p-47">In CGEM, the top gene was the phospholipid/diacylglycerol (DAG)-dependent protein kinase <italic toggle="yes">PRKCQ</italic> <sup>5588</sup> (chr10: 6,540,724-6,573,883), which induces cell migration and invasion.<sup>(<xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">Belguise 2012</xref>; <xref rid="c149" ref-type="bibr" hwp:id="xref-ref-149-1" hwp:rel-id="ref-149">Zafar 2014</xref>)</sup> The same SNP (rs661891) was also implicated in EPIC. The three most significant SNPs and the most significant regions in muGWAS were all located within the same 34 kB LDB. The second most significant gene was a long EST of the transient receptor potential cation channel <italic toggle="yes">TRPM3</italic> <sup>80036</sup>, which controls oncogenic autophagy in renal cell carcinoma,<sup>(<xref rid="c49" ref-type="bibr" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">Hall 2014</xref>)</sup> supported by a part of the promoter region of the shorter main form in PBCS. <italic toggle="yes">BUB3</italic> was also significant in muGWAS, followed by the endo-/lysosomal receptor <italic toggle="yes">SCARB2</italic> <sup>950</sup> and the nuclear RNA polymerase subunit <italic toggle="yes">POLR1A</italic> <sup>25885</sup> (rs10779967).</p><p hwp:id="p-48">In EPIC, the top gene in muGWAS (as in ssGWAS), was the TF <italic toggle="yes">SOHLH2</italic>, followed by <italic toggle="yes">AGPAT3</italic> <sup>56894</sup> (rs8132053 in CGEM and EPIC), whose paralog <italic toggle="yes">AGPAT4</italic> <sup>56895</sup> is included in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-4-4" hwp:rel-id="F4">Fig 1</xref> (4.94, right panel, CGEM). <italic toggle="yes">CELF2</italic> <sup>10659</sup>, an RNA binding protein, and <italic toggle="yes">STARD13</italic> <sup>10948</sup>, a breast cancer tumor suppressor that regulates cell migration and invasion <sup>(<xref rid="c50" ref-type="bibr" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">Hanna 2014</xref>)</sup> also reached aGWS. <italic toggle="yes">CHD</italic> <sup>364663</sup> depends entirely on SNP rs4791889 (see Statistical Methods, 2.2. Replication, for replication criteria).</p><p hwp:id="p-49">In PBCS, the top gene in muGWAS, as in ssGWAS, was <italic toggle="yes">DOCK8</italic> <sup>81704</sup>, followed by the nuclear receptor corepressor <italic toggle="yes">NCOR2</italic> <sup>9612</sup>, which has been implicated in tamoxifen resistance in breast cancer.<sup>(<xref rid="c125" ref-type="bibr" hwp:id="xref-ref-125-1" hwp:rel-id="ref-125">van Agthoven 2009</xref>; <xref rid="c150" ref-type="bibr" hwp:id="xref-ref-150-1" hwp:rel-id="ref-150">Zhang 2013b</xref>)</sup> <italic toggle="yes">CACNA1C</italic> <sup>775</sup> (3<sup>rd</sup>) is highly up-regulated in breast cancer.<sup>(<xref rid="c130" ref-type="bibr" hwp:id="xref-ref-130-1" hwp:rel-id="ref-130">Wang 2015a</xref>)</sup> The multiple epidermal GF-like domains protein 11 (<italic toggle="yes">MEGF11</italic> <sup>84465</sup>, 4<sup>th</sup>), like <italic toggle="yes">MEGF10</italic> <sup>84466</sup>an ortholog of <italic toggle="yes">C. elegans</italic> Ced-1 and the <italic toggle="yes">Drosophila</italic> draper, had been implicated in colorectal cancer. <sup>(<xref rid="c18" ref-type="bibr" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">Cicek 2012</xref>)</sup></p><p hwp:id="p-50">Both CGEM and EPIC have a significant P-type ATPase, which import phosphatidylserine (PS, <italic toggle="yes">ATP8B1</italic> <sup>5205</sup>) and phosphatidylcholine (PC, <italic toggle="yes">ATP8A1</italic> <sup>10396</sup>), respectively, the substrates for phos-pholipase D (PLD) to produce phosphatidic acid (PA) for the synthesis of phosphatidylinositol (PI).<sup>(<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">Daleke 2007</xref>)</sup> <italic toggle="yes">BMP7</italic> <sup>655</sup> (ss: 4.24) and its receptor <italic toggle="yes">BMPR1B</italic> <sup>658</sup> (ss: 4.47) are significant in EPIC and CGEM, respectively, and BMP signaling is known to regulates mitotic checkpoint protein levels in human breast cancer cells, including levels of <italic toggle="yes">BUB3</italic> (see above).<sup>(<xref rid="c147" ref-type="bibr" hwp:id="xref-ref-147-1" hwp:rel-id="ref-147">Yan 2012</xref>)</sup> <italic toggle="yes">DGKQ</italic> <sup>1609</sup> (rs2290405) which converts DAG into PA, was replicated in CGEM and PBCS, while <italic toggle="yes">LPPR1</italic> <sup>54886</sup>, which is involved in the conversion of PA into PI was replicated in CGEM and EPIC.</p><p hwp:id="p-51">As expected in samples from the general population, the known risk factors for rare early-onset breast cancer (<italic toggle="yes">BRCA1/2</italic> <sup>672/675</sup>, <italic toggle="yes">HER2</italic> <sup>2064</sup>, <italic toggle="yes">RB1</italic> <sup>5925</sup>) do not show association and many receptorrelated genes are absent in ER<sup>-</sup> populations. Except for the genes with highest significance in ssGWAS (<italic toggle="yes">BUB3</italic> in CGEM, <italic toggle="yes">SOHL2</italic> in EPIC, and <italic toggle="yes">DOCK8</italic> in PBCS), all of the aGWS genes in muGWAS have support in least one of the other two populations (2<sup>nd</sup> block of S1 Table 2). This observation is consistent with muGWAS identifying primarily old cis-epistatic variations, rather than <italic toggle="yes">de novo</italic> mutations favored by ssGWAS. S1 Table 2 gives an overview about the significance and replication of the genes identified and supportive evidence in the literature.</p></sec><sec id="s3d" hwp:id="sec-18"><title hwp:id="title-22">muGWAS results confirm known disease pathways in breast cancer</title><p hwp:id="p-52">Consistent with the published results in the NHGRI-EBI catalog, a total of 16, 15, and 18 genes above aGWS in CGEM, EPIC, and PBCS, respectively, are involved in the three known disease pathways, such as membrane-associated receptor signaling (G protein–coupled receptors [GPCR], Fc receptors [FcR], hemagglutinin [HA], receptor tyrosine kinases [RTK], or ion channels), MAP kinases, and in nuclear proteins involved in cell cycle control, transcription, or splicing in breast cancer (Table 1).</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1:</label><caption hwp:id="caption-4"><title hwp:id="title-23">Breast cancer genes associated with pathways by Study.</title><p hwp:id="p-53">Each block of columns shows the genes identified sorted by s-values in muGWAS (s6) down and ssGWAS (s1) up; top: genes above aGWS in muGWAS (CGEM: 5.29, EPIC: 5.71, PBCS: 5.13); bottom: genes with SNPs above aGWS in ssGWAS only (CGEM: 4.03, EPIC: 4.00, PBCS: 3.84, ssGWAS results for genes also implicated in muGWAS are shown next to the muGWAS results); center: other genes shown in <xref ref-type="fig" rid="fig1" hwp:id="xref-fig-4-5" hwp:rel-id="F4">Fig 1</xref>; Mbrn (green): membrane-associated genes (GPCR, FcR, HA, RTK, Ion channels), PI/EC (pink): PI cycle/EEC, MPK (violet): MAP kinases, Ncls (blue): nucleus (cell cycle control, transcription, splicing). See S1 Table 1 for Entrez Gene identifiers and S1 Table 2 for replication across populations, which is indicated in bold.</p></caption><graphic xlink:href="152405_tbl1" position="float" orientation="portrait" hwp:id="graphic-8"/></table-wrap></sec><sec id="s3e" hwp:id="sec-19"><title hwp:id="title-24">muGWAS results highlight Endo-/Exocytosis (EEC) as a pathway in breast cancer</title><p hwp:id="p-54">The cell’s major fibronectin-binding integrin (α5β1) is key to the survival and migration of tumor cells.<sup>(<xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">Dozynkiewicz 2012</xref>)</sup> Results of various expression and functional studies have pointed to EEC of β1 integrins as a functional component of “derailed endocytosis” in cancers, including breast cancer (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-5-1" hwp:rel-id="F5">Fig 2</xref>).<sup>(<xref rid="c93" ref-type="bibr" hwp:id="xref-ref-93-2" hwp:rel-id="ref-93">Mosesson 2008</xref>; Morgan 2009; De <xref rid="c29" ref-type="bibr" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">Franceschi 2015</xref>)</sup>.</p><p hwp:id="p-55">Among the 15 GWS genes not associated with known pathways in the NHGRI-EBI catalog (excluding the ambiguous locus between <italic toggle="yes">MDM4</italic> <sup>4194</sup> and <italic toggle="yes">PIK3C2B</italic> <sup>5287</sup>), only four are involved in EEC (<italic toggle="yes">PDE4D</italic>, <italic toggle="yes">SNX32</italic>, <italic toggle="yes">STXBP4</italic>, <italic toggle="yes">DNAJC1</italic>, marked with “*” in S1 Table 1), all from ssGWAS of a combined analysis of nine studies,<sup>(<xref rid="c88" ref-type="bibr" hwp:id="xref-ref-88-1" hwp:rel-id="ref-88">Michailidou 2013</xref>)</sup> which includet the three studies analyzed separately here. A String<sup>(<ext-link l:rel="related" l:ref-type="uri" l:ref="http://string-db.org/" ext-link-type="uri" xlink:href="http://string-db.org/" hwp:id="ext-link-3">http://string-db.org/</ext-link>)</sup> pathway analysis of the subset of aGWS genes that are not part of the above three pathways identified two clusters related to EEC:
<list list-type="bullet" hwp:id="list-3"><list-item hwp:id="list-item-6"><p hwp:id="p-56"><bold>EEC Function:</bold> <italic toggle="yes">PARK2</italic>, <italic toggle="yes">PTEN (from PTENP1)</italic>, <italic toggle="yes">SYNJ2</italic>, <italic toggle="yes">STXBP1</italic>, <italic toggle="yes">UNC13</italic> (consistent with previous functional studies, see S1 Table 3)</p></list-item><list-item hwp:id="list-item-7"><p hwp:id="p-57"><bold>EEC Regulation:</bold> <italic toggle="yes">AGPAT3</italic> and <italic toggle="yes">DGKQ</italic> (S1 Fig 4).</p></list-item></list></p></sec><sec id="s3f" hwp:id="sec-20"><title hwp:id="title-25">muGWAS identified genes causing dysfunction of EEC, a known BC risk factor</title><p hwp:id="p-58">Further String subset analyses and a literature review by the authors identified additional aGWS genes as related to EEC-related KEGG pathways (genes in parenthesis replaced by a related gene with known function in String). They include endocytosis (hsa04144): <italic toggle="yes">DNM1</italic> (from <italic toggle="yes">MEGF11)</italic>, <italic toggle="yes">EEA1</italic>, <italic toggle="yes">PDE4D</italic>, <italic toggle="yes">SNX32</italic>, <italic toggle="yes">NEDD4</italic> (from <italic toggle="yes">N4BP3</italic>) (FDR =.018) and synaptic vesicle cycle (hsa04721): <italic toggle="yes">STXBP1</italic>, <italic toggle="yes">UNC13C, VAMP2</italic>; (FDR =.0001).</p><p hwp:id="p-59"><bold>Error! Reference source not found.</bold> integrates the genes identified in the present GWAS analysis (pink, see S1 Table 1 for details) with results from expression and functional studies of β1 integrin EEC in breast cancer (see S1 Table 3 for details).</p></sec><sec id="s3g" hwp:id="sec-21"><title hwp:id="title-26">muGWAS identifies PI cycle dysregulation as novel breast cancer risk factor</title><p hwp:id="p-60">In relation to EEC regulation, both CGEM and EPIC identified a phospholipid-translocating ATPase, <italic toggle="yes">ATP8B1</italic> (PE) and <italic toggle="yes">ATP8A1</italic> (PS), respectively. <italic toggle="yes">AGPAT3</italic> is the second most significant gene in EPIC (mu: 6.59, ss: 4.73); <italic toggle="yes">AGPAT4</italic> is among the supportive genes in CGEM (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-4-6" hwp:rel-id="F4">Fig 1</xref>, mu: 4.94). Both acyltransferases transform LPA into PA. CGEM also identified the scramblase <italic toggle="yes">ANO4</italic> <sup>121601</sup> (ss: 4.21), a PS exporter, and the plasma membrane PC/PS efflux pump <italic toggle="yes">ABCA1</italic> <sup>19</sup> (mu: 4.99). For (<italic toggle="yes">ATP8A1</italic>, <italic toggle="yes">ATP8B1</italic>, <italic toggle="yes">ANO4</italic>, <italic toggle="yes">ABCA1),</italic> String identified functional enrichment in</p><p hwp:id="p-61">GO:0097035 (biol. process) Regulation of membrane lipid distribution: FDR = 0.012</p><p hwp:id="p-62">GO:0015914 (biol. process) phospholipid transport: 0.0407</p><p hwp:id="p-63">GO:0005548 (mol. function) phospholipid transporter activity: 0.00968</p><p hwp:id="p-64">As shown in <xref ref-type="fig" rid="fig4" hwp:id="xref-fig-7-1" hwp:rel-id="F7">Fig 4</xref> (upper left corner), 8 (including 6 aGWS) genes are involved in providing the PI cycle with its substrate, PI (and the MAPK signaling pathway with PA.<sup>(hsa 04072)</sup>).</p><fig id="fig4" position="float" fig-type="figure" orientation="portrait" hwp:id="F7" hwp:rev-id="xref-fig-7-1 xref-fig-7-2 xref-fig-7-3 xref-fig-7-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/FIG4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F7</object-id><object-id pub-id-type="publisher-id">fig4</object-id><label>Fig 4:</label><caption hwp:id="caption-5"><title hwp:id="title-27">Functional relation of the PI/EC genes.</title><p hwp:id="p-65">PI is synthesized from myo-inositol (imported by HMIT) and PA (via CDP-DAG) which can be synthesized from lysophosphatic acid (LPA), PC, or PS, or salvaged from IP<sub>3</sub> and DAG. It can also be synthesized from 1-acyl GPI. Arrows: PIs are phosphorylated at a 3-, 4-, or 5position by PI-kinases (left to right) and hydrolyzed by phosphatases (right-to-left). Genes associated with breast cancer in this GWAS are highlighted in pink (bold: aGWS). See Table 1 for other box colors. Colored arrows in the center indicate the sequence of PIs involved in EEC (<bold>Error! Reference source not found.</bold>). Percent values indicate approximate proportion of phospholipids.<sup>(<xref rid="c128" ref-type="bibr" hwp:id="xref-ref-128-1" hwp:rel-id="ref-128">Viaud 2016</xref>)</sup>.</p></caption><graphic xlink:href="152405_fig4" position="float" orientation="portrait" hwp:id="graphic-9"/></fig><fig id="fig5" position="float" fig-type="figure" orientation="portrait" hwp:id="F8"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/FIG5</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F8</object-id><object-id pub-id-type="publisher-id">fig5</object-id><label>Fig 5:</label><caption hwp:id="caption-6"><title hwp:id="title-28">Structure of cyclodextrins.</title><p hwp:id="p-66">Cyclodextrins are toroids formed of six (n=4, αCD), seven (n=5, βCD), or eight (n=6, YCD) starch molecules. The cavity is lipophilic, while the surface is hydrophilic.</p></caption><graphic xlink:href="152405_fig5" position="float" orientation="portrait" hwp:id="graphic-10"/></fig></sec><sec id="s3h" hwp:id="sec-22"><title hwp:id="title-29">Results for EEC regulation and function are consistent across populations</title><p hwp:id="p-67">All three populations show aGWS association with EEC genes (CGEM: 4 in ssGWAS only / 4 in muGWAS only / one in both ; EPIC: 1/0/3; PBCS: 3/1/3). Most are validated in at least one of the other two populations, either by the same SNP involved (<italic toggle="yes">AGPAT3</italic>, <italic toggle="yes">DGKQ</italic>), the same region (<italic toggle="yes">SYNJ2</italic>, <italic toggle="yes">PDE4D</italic>), the same gene (see S1 Fig 5), or a functionally related gene (<italic toggle="yes">AGPAT3</italic>/<italic toggle="yes">AGPAT4</italic>, <italic toggle="yes">LPPR1</italic>/<italic toggle="yes">DGKQ</italic>, <italic toggle="yes">ATP8A1</italic>/<italic toggle="yes">ATP8B1</italic>, <italic toggle="yes">STXBP1</italic>/<italic toggle="yes">UNC13C</italic>, <italic toggle="yes">TNS1</italic>/<italic toggle="yes">PTENP1</italic>, see S1 Table 2 for details).</p></sec><sec id="s3i" hwp:id="sec-23"><title hwp:id="title-30">PI supply into the PI cycle as a drug target in breast cancer</title><p hwp:id="p-68">After loss-of-function in <italic toggle="yes">PTEN</italic> and gain-of-function in <italic toggle="yes">PI3K</italic> suggested a mechanism for upregulation of PI(3,4,5)P<sub>3</sub> in cancer, blocking <italic toggle="yes">PI3K</italic> with Wortmannin<sup>(<xref rid="c105" ref-type="bibr" hwp:id="xref-ref-105-1" hwp:rel-id="ref-105">Powis 1995</xref>)</sup> or related drugs <sup>(<xref rid="c86" ref-type="bibr" hwp:id="xref-ref-86-1" hwp:rel-id="ref-86">McNamara 2011</xref>)</sup> were considered for treatment of cancers, including breast cancer. Upregulation in PI(3,4)P<sub>2</sub> (gain-of-function in <italic toggle="yes">SYNJ1/2</italic> or <italic toggle="yes">INPPL1</italic><sup>(<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">Bunney 2010</xref>)</sup>) and PI(3)P (gain-of-function in <italic toggle="yes">INPP4B</italic>),<sup>(<xref rid="c142" ref-type="bibr" hwp:id="xref-ref-142-1" hwp:rel-id="ref-142">Woolley 2015</xref>)</sup> have also been associated with breast cancer. Recently, components to lower PI(3,4)P<sub>2</sub> by inhibiting <italic toggle="yes">SYNJ2</italic> have been identified.<sup>(<xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">Ben-Chetrit 2015</xref>)</sup></p><p hwp:id="p-69">Targeting individual phosphotransferases is unlikely to succeed given the robustness of the PI cycle.<sup>(<xref rid="c105" ref-type="bibr" hwp:id="xref-ref-105-2" hwp:rel-id="ref-105">Powis 1995</xref>)</sup> All PIs regulating EEC, except for the evolutionarily recent <italic toggle="yes">MTMR1</italic> link (<xref ref-type="fig" rid="fig4" hwp:id="xref-fig-7-2" hwp:rel-id="F7">Fig 4</xref>), are regulated by both three kinases and three groups of phosphatases. Given the plethora of genes involved in EEC (<bold>Error! Reference source not found.</bold>) identifying the appropriate set of phosphotransferase for a given patient to interfere with endocytosis or to correct for functional deficits in exocytosis may be impractical.</p><p hwp:id="p-70">Regulating EEC by controlling the availability of phospholipids, however, while leaving functional interactions within the PI cycle intact, may be feasible. In fact, adding of either exogenous PS or PE led to an enhancement of endocytosis.<sup>(<xref rid="c34" ref-type="bibr" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">Farge 1999</xref>)</sup> As EEC is an essential and highly conserved mechanism for tissue morphogenesis <sup>(<xref rid="c33" ref-type="bibr" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">Emery 2006</xref>; <xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">Bokel 2014</xref>)</sup> and neuronal migration,<sup>(<xref rid="c137" ref-type="bibr" hwp:id="xref-ref-137-1" hwp:rel-id="ref-137">Wilson 2010</xref>; <xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">Cosker 2014</xref>; <xref ref-type="bibr" rid="c64" hwp:id="xref-ref-64-1" hwp:rel-id="ref-64">Kawauchi 2015</xref>)</sup> loss-of-function mutations would likely terminate embryonal development. Accordingly, the overall effect of the variations identified (S1 Table 3) is likely gain-of-function.</p></sec><sec id="s3j" hwp:id="sec-24"><title hwp:id="title-31">HPaCD is more effective than HPbCD against migration of breast cancer cells</title><p hwp:id="p-71">In 2014, it was reported that the benefit attributed to the neurosteroid allopregnanolone in the treatment of Niemann-Pick type C (NPC) disease was due to the expedient, 2-hydroxypropylbeta-cyclodextrin (HPβCD). Cyclodextrins are hydrophilic rings of ≥6 starch molecules (<bold>Error! Reference source not found.</bold>). The lipophilic cavity can transport lipid drugs, such as allopregnanolone. Empty CDs, at therapeutic doses, form a pool in the aqueous phase into which, in the case of βCDs, cellular cholesterol is extracted,<sup>(<xref rid="c95" ref-type="bibr" hwp:id="xref-ref-95-1" hwp:rel-id="ref-95">Ohtani 1989</xref>)</sup> the mechanism of action in NPC.<sup>(<xref rid="c126" ref-type="bibr" hwp:id="xref-ref-126-1" hwp:rel-id="ref-126">Vance 2014</xref>)</sup></p><p hwp:id="p-72">Given the focus on cholesterol in NPC, it has often been overlooked that βCDs also scavenge phospholipids. The above GWAS results (Table 1) suggested defects in phospholipid, rather than cholesterol function. Hence, the efficacy of HPβCD in breast cancer might be due to its ability to scavenge phospholipids.</p><p hwp:id="p-73">HPβCD is known to inhibit migration of human MDA-MB 231 breast cancer cells.<sup>(<xref rid="c79" ref-type="bibr" hwp:id="xref-ref-79-1" hwp:rel-id="ref-79">Liu 2007</xref>; <xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">Donatello 2012</xref>; <xref rid="c44" ref-type="bibr" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">Guerra 2016</xref>, <xref ref-type="fig" rid="fig3" hwp:id="xref-fig-6-3" hwp:rel-id="F6">Figure 3B</xref>)</sup> To determine whether inhibition of migration is caused by HPβCD depleting cholesterol, as assumed previously, or by it depleting phospholipids, as implicated by the novel genetics results, the published activity from wound healing experiments comparing HPβCD against control was replicated, and complemented with novel activity results comparing HPαCD against control,,both in MDA-MB 231 (ER<sup>−</sup>) and MCF-7 (ER<sup>+</sup>) human breast epithelial cell lines.</p><p hwp:id="p-74">From <xref ref-type="fig" rid="fig6" hwp:id="xref-fig-9-1" hwp:rel-id="F9">Fig 6</xref>, 1 mM HPαCD is more effective than 2 mM HPβCD against migration of ER<sup>-</sup> and ER<sup>+</sup> tumor cells (p=.0252) while more than 10× less toxic,<sup>(<xref rid="c73" ref-type="bibr" hwp:id="xref-ref-73-1" hwp:rel-id="ref-73">Leroy-Lechat 1994</xref>)</sup> Hence, the effect previously seen with HPβCD is, in fact, likely the effect of it scavenging phospholipids, rather than cholesterol.</p><fig id="fig6" position="float" fig-type="figure" orientation="portrait" hwp:id="F9" hwp:rev-id="xref-fig-9-1 xref-fig-9-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;152405v2/FIG6</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F9</object-id><object-id pub-id-type="publisher-id">fig6</object-id><label>Fig 6:</label><caption hwp:id="caption-7"><title hwp:id="title-32">Wound healing by cyclodextrins in breast cancer cell lines.</title><p hwp:id="p-75">Cells were grown in triplicates for 12 h and incubated with either of the CDs for 2 h at the concentration indicated (0–4 mM), before a 0.9 mm wide gap was opened and cells were allowed to migrate into the “wound” for 12 h.</p><p hwp:id="p-76">HPβCD is more than 10 × as toxic as HPαCD, which at &lt; 100 mM does not affect epithelial cell viability.<sup>(Leroy-Lechat 1994; <xref rid="c113" ref-type="bibr" hwp:id="xref-ref-113-1" hwp:rel-id="ref-113">Roka 2015</xref>)</sup></p><p hwp:id="p-77">Dashed horizontal line indicates inhibition of wound healing in HPαCD at 1 and 4 mM respectively.</p><p hwp:id="p-78"><bold>ANOVA results:</bold></p><p hwp:id="p-79">indep: HPαCD vs HPβCD (fixed) block: MCF-7/MDA-MB-231 (fixed) dep: %change in wound healing</p><p hwp:id="p-80">1 mM α vs 1 mM β, p =.0001 ***</p><p hwp:id="p-81">1 mM α vs 2 mM β, p =.0252 *</p><p hwp:id="p-82">4 mM α vs 4 mM β, p =.0442 *</p></caption><graphic xlink:href="152405_fig6" position="float" orientation="portrait" hwp:id="graphic-11"/></fig></sec></sec><sec id="s4" hwp:id="sec-25"><title hwp:id="title-33">Discussion</title><p hwp:id="p-83">Our analysis confirmed previous GWAS, which pointed to receptor/AKT signaling and nuclear functions as critical components in breast cancer etiology. The present results from a reanalysis of data found previously inconclusive provides the first GWAS evidence for the contribution of EEC dysfunction and novel evidence for overstimulation of EEC in mesenchymal tumor cell migration and invasion. These findings, confirmed by an <italic toggle="yes">in vitro</italic> study on the activity of HPαCD vs HPβCD against breast cancer cell migration, suggest the novel hypothesis that reducing the influx of phospholipids, including PS, PC, and lysophosphatidylcholine (LPC), into the PI cycle via HPαCD may provide an urgently needed treatment option against metastases in TNBC.</p><sec id="s4a" hwp:id="sec-26"><title hwp:id="title-34">Replication and complementation of previously identified genes</title><p hwp:id="p-84">A previous analysis of the CGEM data reported only two genes, <italic toggle="yes">FGFR2</italic> and <italic toggle="yes">BUB3,</italic> as risk factors for breast cancer. The EPIC and PBCS data have been published only as part of three meta-analysis, which also included CGEM. Among ER<sup>-</sup> cases, the first meta-analysis <sup>(<xref rid="c118" ref-type="bibr" hwp:id="xref-ref-118-3" hwp:rel-id="ref-118">Siddiq 2012</xref>)</sup> confirmed two SNPs each in <italic toggle="yes">BABAM1</italic> (7.31) (a nuclear <italic toggle="yes">BRCA1</italic> complex component), <italic toggle="yes">PTHLH</italic> (12.8) (which regulates epithelial-mesenchymal interactions during the formation of mammary glands), and the ER <italic toggle="yes">ESR1</italic> (9.6). Our findings of <italic toggle="yes">BMP7</italic> (EPIC) and <italic toggle="yes">BMPRT1B</italic> (CGEM) are consistent with the previous finding of <italic toggle="yes">PTHLH,</italic> which forms a nuclear complex with <italic toggle="yes">BMP4</italic>. The second meta-analysis,<sup>(<xref rid="c39" ref-type="bibr" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">Garcia-Closas 2013</xref>)</sup> pointed to the <italic toggle="yes">PIK3C2B-MDM4</italic> region (11.68), <italic toggle="yes">LGR6</italic> (7.85) (a GPCR), and <italic toggle="yes">FTO</italic> (7.40) (a regulator of nuclear mRNA splicing). Hence, ssGWAS in all three populations point to receptor/AKT signaling and nuclear processes, although the individual genes differ.</p><p hwp:id="p-85">Three of the four EEC genes identified in previous ssGWAS;<sup>(<xref rid="c88" ref-type="bibr" hwp:id="xref-ref-88-2" hwp:rel-id="ref-88">Michailidou 2013</xref>)</sup> were confirmed in muGWAS at aGWS/2 (CGEM: 2.56 / EPIC: 2.86 / PBCS: 2.57, S1 Table 1) in regions in LD (r<sup>2</sup>):<sup>(<xref rid="c83" ref-type="bibr" hwp:id="xref-ref-83-1" hwp:rel-id="ref-83">Machiela 2015</xref>)</sup>
<disp-formula id="ueqn2" hwp:id="disp-formula-2">
<alternatives hwp:id="alternatives-2"><graphic xlink:href="152405_ueqn2.gif" position="float" orientation="portrait" hwp:id="graphic-12"/></alternatives>
</disp-formula></p><p hwp:id="p-86">The EEC genes identified in here (with the exception of <italic toggle="yes">AGPAT3/4</italic>, <italic toggle="yes">ASTN2</italic>, and <italic toggle="yes">EEA1</italic>), have previously been shown to be associated with breast cancer in gene expression and functional studies (S1 Table 1).</p><p hwp:id="p-87">A third meta-analysis <sup>(<xref rid="c57" ref-type="bibr" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">Hoffman 2017</xref>)</sup> based the above three and eleven other U4C data sets, identified five novel breast cancer genes, three with nuclear function (<italic toggle="yes">RCCD1</italic>, <italic toggle="yes">ANKL1</italic>, <italic toggle="yes">DHODH</italic> <sup>(<xref rid="c91" ref-type="bibr" hwp:id="xref-ref-91-1" hwp:rel-id="ref-91">Mohamad Fairus 2017</xref>)</sup>); <italic toggle="yes">ACAP1</italic> and <italic toggle="yes">LRRC25</italic> were hypothesized to be involved in cell proliferation (activating Arf6 protein) and inflammatory response (activating hematopoietic cells), respectively, <sup>(<xref rid="c57" ref-type="bibr" hwp:id="xref-ref-57-2" hwp:rel-id="ref-57">Hoffman 2017</xref>)</sup> In fact, both genes are can be related to EEC/PI in metastases: <italic toggle="yes">ACAP1</italic> (<bold>Error! Reference source not found.</bold>, top right) regulates recycling of integrin β1 during cell migration <sup>(Li</sup> <sup>2005)</sup>; <italic toggle="yes">LRRC25</italic>, which regulates development of neutrophils needed for metastases,<sup>(<xref rid="c20" ref-type="bibr" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">Coffelt 2016</xref>)</sup> carries a PI3K interaction motive.<sup>(<xref rid="c78" ref-type="bibr" hwp:id="xref-ref-78-1" hwp:rel-id="ref-78">Liu 2017</xref>)</sup></p><sec id="s4b" hwp:id="sec-27"><title hwp:id="title-35">Computational biostatistics approach to genetic data</title><p hwp:id="p-88">The analysis approach,<sup>(<xref rid="c139" ref-type="bibr" hwp:id="xref-ref-139-4" hwp:rel-id="ref-139">Wittkowski 2013</xref>)</sup> used here integrates genetics concepts into the statistical method, rather than considering them during visual inspection of p-values calculated one SNP at a time and correlations among SNPs within an LDB. In particular, muGWAS avoids assumptions about the degree of dominance, reflects that both SNPs next to a disease locus should be in LD (unless they are separated by a recombination hotspot), increases resolution within LDBs (by distinguishing between members of the same tag sets being in a different order), integrates information from different disease loci within the same region (similar effects, compound heterozygosity), and draws on a measure of “information content” to prioritize results.</p><p hwp:id="p-89">Screening for cis-epistatic regions (which may plausibly have evaded selective pressure) prioritizes biologically plausible results while de-emphasizing individual SNPs, which may be significant because of population selection biases, unless they cause exclusively late-onset phenotypes, such as age-related macular degeneration.<sup>(<xref rid="c68" ref-type="bibr" hwp:id="xref-ref-68-1" hwp:rel-id="ref-68">Klein 2005</xref>)</sup> Avoiding strong model assumptions (additivity, independence) reduces model misspecification biases. Increasing the sample size, instead, does not guard against these biases, so that imposing a higher fixed GWS level in ssGWAS may, somewhat counterintuitively, favor “false positives” over biologically plausible cisepistatic effects. The main limitation of u-statistics for multivariate data (conceived in the 1940s <sup>(<xref ref-type="bibr" rid="c56" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">Hoeffding 1948</xref>)</sup>) is that the amount of memory required became available only with 32-bit operating systems, in 2001, and computations became feasible only with the advent of GPU-enabled cloud computing.</p><p hwp:id="p-90">To improve upon the conventional “overly conservative correction”<sup>(<xref rid="c99" ref-type="bibr" hwp:id="xref-ref-99-2" hwp:rel-id="ref-99">Pearson 2008</xref>)</sup> of 7.3, a systematic analysis of GWA studies suggested lowering the GWS level to 7.0 (fixed),<sup>(<xref rid="c98" ref-type="bibr" hwp:id="xref-ref-98-2" hwp:rel-id="ref-98">Panagiotou 2012</xref>)</sup> and then further by using study-specific empirical approaches.<sup>(<xref rid="c4" ref-type="bibr" hwp:id="xref-ref-4-4" hwp:rel-id="ref-4">Aslibekyan 2013a</xref>)</sup> The empirical aGWS decision rule used here accounts for GWAS not being randomized, the absence of a traditional ‘null hypothesis’ in a heritable disease, differences in MAF causing the expected distributions in a QR plot to be convex, and tests in overlapping diplotypes being related.<sup>(<xref rid="c138" ref-type="bibr" hwp:id="xref-ref-138-9" hwp:rel-id="ref-138">Wittkowski 2014</xref>)</sup></p><p hwp:id="p-91">The combination of a method with higher specificity and a decision strategy with higher sensitivity increased the number of genes above the cut-off while ensuring that the vast majority ofgenes implicated was related to known pathways in breast cancer etiology, including dysregulation of EEC.</p></sec><sec id="s4c" hwp:id="sec-28"><title hwp:id="title-36">Replication of findings across populations</title><p hwp:id="p-92">Conventionally, a lower GWS level required for replication. At the aGWS/2 level, none of most significant ssGWAS results (CGEM: <italic toggle="yes">FGFR2</italic>, <italic toggle="yes">BUB3</italic>, <italic toggle="yes">MMRN1</italic>; EPIC: <italic toggle="yes">CHD3</italic>, <italic toggle="yes">SOHLH2</italic>; PBCS: <italic toggle="yes">DOCK8</italic>) was replicated in another population (S1 Table 2). Only three genes (<italic toggle="yes">AGPAT3</italic>, <italic toggle="yes">MEGF11</italic>, and <italic toggle="yes">TRAPPC9</italic>) were replicated in both of the other populations, but none for the same SNP. These results are consistent with common lack of replication in ssGWAS.<sup>(<xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-1" hwp:rel-id="ref-60">Ioannidis 2013</xref>)</sup> With muGWAS, in contrast, many genes were replicated in at least one population and seven genes were replicated in both of the other populations (<italic toggle="yes">FGFR2</italic>, <italic toggle="yes">TRPM3</italic>, <italic toggle="yes">AGPAT3</italic>, <italic toggle="yes">NCOR2</italic>, <italic toggle="yes">MEGF11</italic>, <italic toggle="yes">GPC6</italic>, and <italic toggle="yes">RGS3</italic>), although not necessarily in the same intragenic region. Hence, analyses combining the data from several studies (often called “meta-analyses”, even when subject-level data is used) may result in some populations diluting the risk factors present in others.<sup>(<xref ref-type="bibr" rid="c60" hwp:id="xref-ref-60-2" hwp:rel-id="ref-60">Ioannidis 2013</xref>)</sup></p><p hwp:id="p-93">Our results are consistent with ssGWAS finding recent, highly penetrant mutations, which may differ across populations, while muGWAS has higher power for common cis-epistatic variations, which are more likely to be shared across populations. Even more likely to be shared are genes that carry different variations and different genes with similar contribution to the etiology,<sup>(<xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">Aslibekyan 2013b</xref>)</sup> consistent with previous findings that breast cancer gene expression signatures have little overlap across populations.<sup>(<xref rid="c46" ref-type="bibr" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">Haibe-Kains 2008</xref>)</sup></p></sec><sec id="s4d" hwp:id="sec-29"><title hwp:id="title-37">Dysregulated EEC in breast cancer metastasis, angiogenesis, and progression</title><p hwp:id="p-94">Genes involved in EEC (e.g., Rab GTPases) are aberrantly expressed in human cancers.<sup>(<xref rid="c93" ref-type="bibr" hwp:id="xref-ref-93-3" hwp:rel-id="ref-93">Mosesson 2008</xref>)</sup> Dysregulation of endocytosis-mediated recycling of oncoproteins (e.g., GF receptors and adhesion molecules, including integrins and annexins), can promote progression, migration, and invasion <sup>(<xref rid="c93" ref-type="bibr" hwp:id="xref-ref-93-4" hwp:rel-id="ref-93">Mosesson 2008</xref>; <xref rid="c84" ref-type="bibr" hwp:id="xref-ref-84-1" hwp:rel-id="ref-84">Maji 2016</xref>)</sup>. Cell migration and invasion, which are promoted by EEC of integrins, are also essential features of angiogenesis.<sup>(<xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">Demircioglu 2016</xref>)</sup> In addition, endocytic uptake of lipoproteins is critical for adaptation of cancer to its microenvironment.<sup>(<xref rid="c87" ref-type="bibr" hwp:id="xref-ref-87-1" hwp:rel-id="ref-87">Menard 2016</xref>)</sup></p><p hwp:id="p-95">Tumor-derived exosomes, 30–150 nm sized extracellular vesicles formed by dysregulated EEC, are critical mediators of intercellular communication between tumor cells and recipient stromal cells in both local and distant microenvironments.<sup>(<xref rid="c22" ref-type="bibr" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">Costa-Silva 2015</xref>; <xref rid="c151" ref-type="bibr" hwp:id="xref-ref-151-1" hwp:rel-id="ref-151">Zhang 2015a</xref>)</sup> Several Rab proteins (Rab2b/5a/9a/27a/27b) are known to function in the selective packaging and production of exosomes in tumor cells (<bold>Error! Reference source not found.</bold>, bottom left).<sup>(<xref rid="c96" ref-type="bibr" hwp:id="xref-ref-96-1" hwp:rel-id="ref-96">Ostrowski 2010</xref>)</sup> Rab27a knockdown in highly metastatic melanoma cells significantly decreased exosome production, primary tumor growth, and metastasis,<sup>(<xref rid="c100" ref-type="bibr" hwp:id="xref-ref-100-1" hwp:rel-id="ref-100">Peinado 2012</xref>)</sup> confirming the role of EEC in generating exosomes.</p><p hwp:id="p-96">Dysregulated EEC alters not only exosome biogenesis (vesicular packaging and trafficking), but also the composition of exosomal cargos. Tumor-specific proteins, such as integrins were enriched in exosomes, transferred between cancer cells,<sup>(<xref rid="c35" ref-type="bibr" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">Fedele 2015</xref>)</sup> and correlated with migration and invasion of recipient cells.<sup>(<xref rid="c51" ref-type="bibr" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">Harris 2015</xref>; <xref rid="c65" ref-type="bibr" hwp:id="xref-ref-65-1" hwp:rel-id="ref-65">Keerthikumar 2015</xref>)</sup> Exosome uptake (involving endocytosis <sup>(<xref rid="c55" ref-type="bibr" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">Heusermann 2016</xref>)</sup>) induces nontumorigenic cells to develop cancer-related phenotypes and the uptake of exosomal integrins promotes migration of these tumor cells.<sup>(<xref rid="c120" ref-type="bibr" hwp:id="xref-ref-120-1" hwp:rel-id="ref-120">Singh 2016</xref>)</sup></p><p hwp:id="p-97">A recent study revealed that exosomal integrin expression patterns enriched in cancer-derived exosomes involve specific αβ combinations matched to target organs. Proteomic analysis revealed that the exosomal integrin αvβ5 binds to Kupffer cells that mediate liver metastasis, integrins α6β1 and α6β4 are associated with lung metastasis in breast cancer, while integrin β1 (which required for extravasation in metastases <sup>(<xref rid="c15" ref-type="bibr" hwp:id="xref-ref-15-1" hwp:rel-id="ref-15">Chen 2016</xref>)</sup>) was not organ-specific. <sup>(<xref rid="c58" ref-type="bibr" hwp:id="xref-ref-58-1" hwp:rel-id="ref-58">Hoshino 2015</xref>)</sup>.</p><p hwp:id="p-98">Additionally, other tumor-specific exosomal proteins, such as annexins (calcium-dependent phospholipid-binding proteins known to regulate membrane trafficking and EEC), which are known to correlate with migration and invasion, are also packaged in cancer exosomes <sup>(<xref rid="c72" ref-type="bibr" hwp:id="xref-ref-72-1" hwp:rel-id="ref-72">Leca 2016</xref>; <xref rid="c84" ref-type="bibr" hwp:id="xref-ref-84-2" hwp:rel-id="ref-84">Maji 2016</xref>)</sup>. Annexins are frequently overexpressed in breast, liver, prostate, and pancreatic cancers and participate in multiple functions in cancer, including angiogenesis, tumor migration and invasion.<sup>(<xref rid="c94" ref-type="bibr" hwp:id="xref-ref-94-1" hwp:rel-id="ref-94">Mussunoor 2008</xref>)</sup> In breast cancer, exosomal annexin A2 promotes angiogenesis and vascularization via tissue plasminogen activator (tPA).<sup>(<xref rid="c84" ref-type="bibr" hwp:id="xref-ref-84-3" hwp:rel-id="ref-84">Maji 2016</xref>)</sup> In pancreatic cancer, exosomal annexin A6 from cancer-associated fibroblasts contributes to tumor cell survival and invasion through annexin A6 / LDL receptor-related protein 1 / thrombospondin 1 complex formation.<sup>(<xref rid="c72" ref-type="bibr" hwp:id="xref-ref-72-2" hwp:rel-id="ref-72">Leca 2016</xref>)</sup></p><p hwp:id="p-99">In summary, EEC plays at least four roles in metastases; preparing the distant microenvironment, spreading the cancer phenotype horizontally, and preparing cancer cells for migration (all via exoand endocytosis of exosomes containing integrins), and facilitating migration and invasion (via increasing EEC of integrins). In each case, both endoand exocytosis are involved, either in donor and target cells or at trailing edge and advancing lamellipodium (<xref ref-type="fig" rid="fig2" hwp:id="xref-fig-5-2" hwp:rel-id="F5">Fig 2</xref>). Hence, down-regulating “de-railed endocytosis”<sup>(<xref rid="c93" ref-type="bibr" hwp:id="xref-ref-93-5" hwp:rel-id="ref-93">Mosesson 2008</xref>)</sup> could have substantial synergistic effects.</p></sec><sec id="s4e" hwp:id="sec-30"><title hwp:id="title-38">The PI cycle in Breast Cancer</title><p hwp:id="p-100">Our findings of <italic toggle="yes">PTENP1</italic> (PBCS), <italic toggle="yes">TNS1</italic> (EPIC), and <italic toggle="yes">SYNJ2</italic> (CGEM) are consistent with known breast cancer mutations in <italic toggle="yes">PI3K/PTEN</italic> <sup>(<xref rid="c127" ref-type="bibr" hwp:id="xref-ref-127-1" hwp:rel-id="ref-127">Varticovski 1991</xref>; <xref rid="c76" ref-type="bibr" hwp:id="xref-ref-76-1" hwp:rel-id="ref-76">Li 1997</xref>)</sup> and <italic toggle="yes">SYNJ2</italic>. That both PI(3,4,5)P<sub>3</sub> and PI(3,4)P<sub>2</sub> are required to achieve and sustain a malignancy, has been formulated as the “two PI hypothesis”<sup>(<xref ref-type="bibr" rid="c67" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">Kerr 2011</xref>)</sup> Except for the known <italic toggle="yes">PRCKQ</italic>, which is regulated by phospholipids via the PI(4,5)P<sub>2</sub>–PLC–DAG route, however, our analysis identified few genes along the <italic toggle="yes">AKT/TSC/mTOR</italic> pathway, which is controlled by the “two PIs”. Instead, our results point to EEC, in which virtually all PIs are involved. The closely related set of genes involved in recycling of DAG (<italic toggle="yes">DGKQ</italic>), influx of PC and PS (<italic toggle="yes">ATP8B1</italic>, <italic toggle="yes">ATP8A1</italic>), and influx of LPA and 1-acyl GPI (<italic toggle="yes">AGPAT3</italic>, <italic toggle="yes">AGPAT4</italic>) suggests the downregulation of circulating phospholipids as a novel strategy to reduce EEC.</p><p hwp:id="p-101">LPA, a known promoter of cell migration and invasion in breast cancer,<sup>(<xref rid="c89" ref-type="bibr" hwp:id="xref-ref-89-1" hwp:rel-id="ref-89">Mills 2003</xref>; <xref rid="c131" ref-type="bibr" hwp:id="xref-ref-131-1" hwp:rel-id="ref-131">Wang 2016</xref>)</sup> is produced from LPC by autotaxin (ATX).<sup>(<xref rid="c10" ref-type="bibr" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">Benesch 2016</xref>)</sup> While <italic toggle="yes">ATX</italic> mouse knockouts are embryonically lethal, mice that overexpress LPA or <italic toggle="yes">ATX</italic> develop spontaneous metastatic mammary tumors. A mechanism mediated by G-coupled LPA receptors may cause mesenchymal tumors via endocytosis upregulation involving β-arrestin2 <sup>(<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">Alemayehu 2013</xref>)</sup> and Arf6.<sup>(<xref rid="c52" ref-type="bibr" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">Hashimoto 2016</xref>)</sup></p><p hwp:id="p-102">LPA and LPC in physiologic concentrations have been shown to strongly induce migration of rhabdomyosarcoma (RMS) cells and to be increased by irradiation and chemotherapy in bone marrow.<sup>(<xref rid="c115" ref-type="bibr" hwp:id="xref-ref-115-1" hwp:rel-id="ref-115">Schneider 2014</xref>)</sup> The authors suggested the development of inhibitors of LPA/LPC signaling or “molecules that bind these bioactive lipids” after radio/chemotherapy. However, targeting a single among several redundant receptor/ligand complex may not be sufficiently effective to prevent metastases.<sup>(<xref rid="c108" ref-type="bibr" hwp:id="xref-ref-108-1" hwp:rel-id="ref-108">Ratajczak 2016</xref>)</sup></p><p hwp:id="p-103">Alkyl-LPCs, which compete with LPC, are in clinical use for treatment of cutaneous metastases in breast cancer, but have shown little activity (and substantial GI side effects) in advanced metastatic breast cancer.<sup>(<xref rid="c111" ref-type="bibr" hwp:id="xref-ref-111-1" hwp:rel-id="ref-111">Ríos-Marco 2017</xref>)</sup> From the results presented here, this is consistent with reducing LPC being most effective while cells are still migrating.</p><p hwp:id="p-104">As our results suggest, overall EEC upregulation may be caused by multiple variations affecting the PI cycle. Thus, reducing EEC by diminishing the overall phospholipid pool might be a more effective breast cancer treatment than blocking one or even two phosphotransferases, a strategy for which the highly robust PI cycle is designed to compensate. Given the ability of biologic systems to prioritize scarce resources, one would expect this effect to be stronger for tumor cells than for host cells whose functions are routinely prioritized when supplies are scarce. A related approach, substituted myo-inositol (MI) analogues, had already been considered, but was found unlikely to be effective <italic toggle="yes">in vivo</italic>, because even physiological concentration of MI antagonized the growth inhibitory activity of such analogues.<sup>(<xref rid="c105" ref-type="bibr" hwp:id="xref-ref-105-3" hwp:rel-id="ref-105">Powis 1995</xref>)</sup></p></sec><sec id="s4f" hwp:id="sec-31"><title hwp:id="title-39">βCDs are effective in cancer models of migration, invasion, and angiogenesis</title><p hwp:id="p-105">A plethora of studies have investigated the effect of methyl-β-cyclodextrin (MβCD) <italic toggle="yes">in vitro</italic>. For instance, MβCD suppressed invasion activity in three H7 Lewis lung cancer cell lines where highly metastatic cell lines had more β1 integrin.<sup>(<xref rid="c152" ref-type="bibr" hwp:id="xref-ref-152-1" hwp:rel-id="ref-152">Zhang 2006</xref>)</sup>. Breast and prostate cancer cell lines were more sensitive to MβCD-induced cell death than their normal counterparts.<sup>(<xref rid="c77" ref-type="bibr" hwp:id="xref-ref-77-1" hwp:rel-id="ref-77">Li 2006</xref>)</sup> In particular, MβCD treatment induced a substantial decrease (40%) in activity of breast cancer resistance protein (<italic toggle="yes">BCRP/ABCG2</italic>),<sup>(<xref rid="c122" ref-type="bibr" hwp:id="xref-ref-122-1" hwp:rel-id="ref-122">Storch 2007</xref>)</sup> which transports PS and PC analogues.<sup>(<xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">Daleke 2007</xref>)</sup> In subsequent functional studies, MβCD inhibited spheroid migration and invasion of MDA-MB-241 and ZR751 breast cancer cells <sup>(<xref rid="c106" ref-type="bibr" hwp:id="xref-ref-106-1" hwp:rel-id="ref-106">Raghu 2010</xref>)</sup> and also endocytosis <sup>(<xref rid="c97" ref-type="bibr" hwp:id="xref-ref-97-1" hwp:rel-id="ref-97">Palaniyandi 2012</xref>)</sup> and migration <sup>(<xref rid="c44" ref-type="bibr" hwp:id="xref-ref-44-2" hwp:rel-id="ref-44">Guerra 2016</xref>)</sup> of MCF7 breast cancer cells. MβCD was more toxic for invasive than for non-invasive urothelial cancer cells,<sup>(<xref rid="c109" ref-type="bibr" hwp:id="xref-ref-109-1" hwp:rel-id="ref-109">Resnik 2015</xref>)</sup> and interfered with RTK-[PI2]-PI3K-[PI3]-AKT signaling in HeLa cells.<sup>(<xref rid="c145" ref-type="bibr" hwp:id="xref-ref-145-1" hwp:rel-id="ref-145">Yamaguchi 2015</xref>)</sup> Finally, MβCD reduced breast cancer-induced osteoclast activity in RAW264.7 cells and osteoclastogenic gene expression in MCF-7 cells.<sup>(<xref rid="c17" ref-type="bibr" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">Chowdhury 2017</xref>)</sup> Sulfated SβCD also inhibits epithelial cell migration and invasion, but not proliferation <sup>(<xref rid="c134" ref-type="bibr" hwp:id="xref-ref-134-1" hwp:rel-id="ref-134">Watson 2013</xref>)</sup> and prevents angiogenesis <italic toggle="yes">ex vivo</italic> in an rat aortic ring assay and an chick embryo collagen onplant assay.<sup>(Watson</sup> <sup>2013)</sup> The relevance of these <italic toggle="yes">in vitro</italic> findings was confirmed by several <italic toggle="yes">in vivo</italic> studies.</p><p hwp:id="p-106">MβCD had higher concentration in tumor than in other cells (except kidney and liver involved in its clearance) and reduced tumor volume in mice xenografted with MCF-7 breast cancer or A2780 ovarian carcinoma cells at least as effectively and with less toxicity than doxycyclin,<sup>(<xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">Grosse 1998</xref>)</sup> reduced the number of lung metastases in mice implanted with H7-O Lewis lung cancer cells,<sup>(<xref rid="c152" ref-type="bibr" hwp:id="xref-ref-152-2" hwp:rel-id="ref-152">Zhang 2006</xref>)</sup> reduced invasiveness of melanoma,<sup>(<xref rid="c36" ref-type="bibr" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">Fedida-Metula 2008</xref>)</sup> and inhibited growth of primary effusion lymphoma (PEL) in mice.<sup>(<xref rid="c41" ref-type="bibr" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">Gotoh 2014</xref>)</sup> HPβCD was necessary in triple combination treatment for tumor regression in mice implanted with renal cancer cells.<sup>(<xref rid="c145" ref-type="bibr" hwp:id="xref-ref-145-2" hwp:rel-id="ref-145">Yamaguchi 2015</xref>)</sup> and prolonged survival in leukemia mouse models.<sup>(<xref rid="c148" ref-type="bibr" hwp:id="xref-ref-148-1" hwp:rel-id="ref-148">Yokoo 2015</xref>)</sup></p><p hwp:id="p-107">However, while HPβCD was effective against tumors in animal models and well tolerated in most peripheral and central organ systems,<sup>(<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">Cronin 2015</xref>)</sup> it was shown to carry the risk of causing permanent hearing loss in mice,<sup>(<xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">Crumling 2012</xref>)</sup> cats,<sup>(<xref rid="c133" ref-type="bibr" hwp:id="xref-ref-133-1" hwp:rel-id="ref-133">Ward 2010</xref>; <xref rid="c129" ref-type="bibr" hwp:id="xref-ref-129-1" hwp:rel-id="ref-129">Vite 2015</xref>)</sup> and at least one human.<sup>(<xref rid="c82" ref-type="bibr" hwp:id="xref-ref-82-1" hwp:rel-id="ref-82">Maarup 2015</xref>)</sup> This ototoxicity is believed to be due to depriving prestin <italic toggle="yes">(SLC26A5</italic>) in outer hair cells of cholesterol. <sup>(<xref rid="c63" ref-type="bibr" hwp:id="xref-ref-63-1" hwp:rel-id="ref-63">Kamar 2012</xref>; <xref rid="c146" ref-type="bibr" hwp:id="xref-ref-146-1" hwp:rel-id="ref-146">Yamashita 2015</xref>; <xref rid="c123" ref-type="bibr" hwp:id="xref-ref-123-1" hwp:rel-id="ref-123">Takahashi 2016</xref>)</sup></p></sec><sec id="s4g" hwp:id="sec-32"><title hwp:id="title-40">Migration and invasion in breast cancer involve cholesterol-unrelated processes</title><p hwp:id="p-108">The role of phospholipids emerging from our results, however, suggests a different mechanism than scavenging of cholesterol. This mechanism is consistent with previously reported <italic toggle="yes">in vivo</italic> results: <italic toggle="yes">CAV1</italic> expression in breast cancer stroma increases tumor migration and invasion <sup>(<xref rid="c40" ref-type="bibr" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">Goetz 2011</xref>)</sup> and <italic toggle="yes">CAV1</italic> is required for invadopodia formation specifically by breast cancer cells, where <italic toggle="yes">CAV1</italic> knockdown cannot be rescued by cholesterol.<sup>(<xref rid="c144" ref-type="bibr" hwp:id="xref-ref-144-1" hwp:rel-id="ref-144">Yamaguchi 2009</xref>)</sup> Growing MDA-MB-231 breast cancer cells in lipoprotein depleted medium resulted in an 85% decrease in cell migration.<sup>(<xref rid="c2" ref-type="bibr" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">Antalis 2011</xref>)</sup> LPA activates the Arf6-based mesenchymal pathway for migration and invasion of renal cancer cells, which also originate from cells located within epithelial ductal structures. <sup>(<xref rid="c63" ref-type="bibr" hwp:id="xref-ref-63-2" hwp:rel-id="ref-63">Kamar 2012</xref>; <xref rid="c146" ref-type="bibr" hwp:id="xref-ref-146-2" hwp:rel-id="ref-146">Yamashita 2015</xref>; <xref rid="c52" ref-type="bibr" hwp:id="xref-ref-52-2" hwp:rel-id="ref-52">Hashimoto 2016</xref>; <xref rid="c123" ref-type="bibr" hwp:id="xref-ref-123-2" hwp:rel-id="ref-123">Takahashi 2016</xref>)</sup></p><p hwp:id="p-109">Limiting the availability PIs would be particularly effective for PI(4)P and PI(4,5)P<sub>2</sub> (each at &lt; 10%, see <xref ref-type="fig" rid="fig4" hwp:id="xref-fig-7-3" hwp:rel-id="F7">Fig 4</xref>) and, thus, would likely reduce endocytosis more than lysosomal degradation. In addition, cyclodextrins have been shown to exert their role in NPC treatment by activating rather than downregulating, Ca-dependent lysosomal exocytosis.<sup>(<xref rid="c14" ref-type="bibr" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">Chen 2010</xref>)</sup></p><p hwp:id="p-110">From the mechanism of βCD in NPC and elevated cholesterol levels seen in several cancers, including breast cancer,<sup>(<xref rid="c148" ref-type="bibr" hwp:id="xref-ref-148-2" hwp:rel-id="ref-148">Yokoo 2015</xref>)</sup> βCDs were thought to reduce cancer growth by lowering cholesterol levels. Early evidence that this might not be the case emerged from the study of exosomes, which play a key role in development of breast cancer.<sup>(<xref rid="c101" ref-type="bibr" hwp:id="xref-ref-101-1" hwp:rel-id="ref-101">Peinado 2011</xref>; <xref rid="c81" ref-type="bibr" hwp:id="xref-ref-81-1" hwp:rel-id="ref-81">Lowry 2015</xref>)</sup> Treatment of MDA-MB-231 breast cancer cells with MβCD inhibited the internalization of exosomes containing integrins,<sup>(<xref rid="c58" ref-type="bibr" hwp:id="xref-ref-58-2" hwp:rel-id="ref-58">Hoshino 2015</xref>)</sup> but did so independently of cholesterol.<sup>(<xref rid="c69" ref-type="bibr" hwp:id="xref-ref-69-1" hwp:rel-id="ref-69">Koumangoye 2011</xref>)</sup></p></sec><sec id="s4h" hwp:id="sec-33"><title hwp:id="title-41">αCD scavenge phospholipids only, reducing AEs and increasing effectiveness</title><p hwp:id="p-111">The effect of βCDs on tumor (and other cells) is widely believed to be due to “cholesterol depletion”,<sup>(<xref rid="c41" ref-type="bibr" hwp:id="xref-ref-41-2" hwp:rel-id="ref-41">Gotoh 2014</xref>; <xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">Badana 2016</xref>)</sup> yet βCDs also scavenges phospholipids.<sup>(<xref rid="c95" ref-type="bibr" hwp:id="xref-ref-95-2" hwp:rel-id="ref-95">Ohtani 1989</xref>)</sup> The genetics results presented here (<xref ref-type="fig" rid="fig4" hwp:id="xref-fig-7-4" hwp:rel-id="F7">Fig 4</xref>) suggest that, at least for breast cancer, the effect of βCDs is related primarily to scavenging of phospholipids. The cavity of αCDs is too small for cholesterol, but large enough for phospholipids. <sup>(<xref rid="c107" ref-type="bibr" hwp:id="xref-ref-107-1" hwp:rel-id="ref-107">Rajnavolgyi 2014</xref>; <xref rid="c117" ref-type="bibr" hwp:id="xref-ref-117-1" hwp:rel-id="ref-117">Shityakov 2016</xref>)</sup> From the <italic toggle="yes">in vitro</italic> results validating the hypothesis generated as part of the U4C challenge (<xref ref-type="fig" rid="fig6" hwp:id="xref-fig-9-2" hwp:rel-id="F9">Fig 6</xref>), αCDs may achieve the same antitumor effect as βCDs, at half the dose and without the risk of cholesterol-related ototoxicity.</p><p hwp:id="p-112">Two types of “controls” have been used: repletion of cholesterol via βCDs “loaded” with cholesterol, and reduction of cholesterol production via statins. Repletion of cholesterol, however, also increases production of phospholipids by freeing acetyl-CoA, the precursor of both phospholipids and cholesterol <sup>(<xref rid="c116" ref-type="bibr" hwp:id="xref-ref-116-1" hwp:rel-id="ref-116">Shiratori 1994</xref>; <xref ref-type="bibr" rid="c110" hwp:id="xref-ref-110-1" hwp:rel-id="ref-110">Ridgway 1999</xref>; <xref ref-type="bibr" rid="c71" hwp:id="xref-ref-71-1" hwp:rel-id="ref-71">Lagace 2015</xref>)</sup> and statins also lower phospholipids.<sup>(<xref rid="c121" ref-type="bibr" hwp:id="xref-ref-121-1" hwp:rel-id="ref-121">Snowden 2014</xref>)</sup> Hence, neither of these two strategies can “controls” against βCDs scavenging phospholipids, rather than cholesterols. Using αCD as a control, however, can answer this question and the above <italic toggle="yes">in vitro</italic> results suggest that equi-molar αCDs are, in fact, at least twice as effective as βCDs, as one would expect if the effect of either CD is caused by its ability to scavenge phospholipids. Hence, our results suggest that many of the previous experiments with βCDs should be redone, this time using αCDs as a control.</p><p hwp:id="p-113">αCD is generally recognized as safe (GRAS)<sup>(FDA, GRN 000155)</sup> and approved as an expedient for i.v. alprostadil.<sup>(<xref rid="c80" ref-type="bibr" hwp:id="xref-ref-80-1" hwp:rel-id="ref-80">Loftsson 2010</xref>)</sup> Due to higher watersolubility, αCD has lower nephrotoxicity than βCD.<sup>(<xref rid="c37" ref-type="bibr" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">Frank 1976</xref>)</sup> HP derivatives of αCD and βCD increase water solubility from 145 and 18.5, respectively to ≥500 g/L. In mice, the observed ototoxicity order of HPβCD &gt;<sub>[p&lt;.002]</sub> HP CD &gt;<sub>[p&lt;.02]</sub> HPαCD [<sub>[NS]</sub> vehicle] matches the reported order for hemolysis and toxicities in various cell types.<sup>(Leroy-Lechat 1994; <xref rid="c28" ref-type="bibr" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">Davidson 2016</xref>)</sup> In humans, a single dose of up to 3 g/kg/d HPβCD and seven daily doses of 1 g/kg/d were reported to have no adverse effects.<sup>(<xref rid="c42" ref-type="bibr" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">Gould 2005</xref>)</sup> In 5-yr old children treated for NPC, 800 mg/kg/d HPβCD i.v. for 12 months was well tolerated.<sup>(<xref ref-type="bibr" rid="c53" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">Hastings 2009</xref>)</sup></p></sec><sec id="s4i" hwp:id="sec-34"><title hwp:id="title-42">HPαCD as a novel treatment in breast cancer</title><p hwp:id="p-114">Given significant redundancy pro-metastatic ligand-receptor complexes, the paradigm of targeting a single receptor-ligand complex has recently been challenged.<sup>(<xref rid="c108" ref-type="bibr" hwp:id="xref-ref-108-2" hwp:rel-id="ref-108">Ratajczak 2016</xref>)</sup> Although targeting EEC is a promising therapeutic strategy to prevent and treat metastasis,<sup>(<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">Chew 2016</xref>)</sup> a therapeutic agent is yet to be determined. Our results suggest that metastases in breast cancer rely on upregulation of the highly robust PI cycle and various types of dysregulation along the complex EEC pathway, rather than a simple linear PI pathway. Hence targeting the PI cycle in its entirety may be more efficective than targeting individual phosphatases or kinases, or specific genes along the EEC pathway. Cyclodextrins are attractive candidates for a polyvalent approach to treat breast cancer. By modulating several pathways involved in breast cancer, such as altering exosome production and packaging, and impede metastatic colonization, CDs are likely to confer greater protective effects than molecules that have single targets. The selectivity of the smaller αCDs to phospholipids would minimize side effects (e.g., ototoxicity) from βCDs also capturing cholesterol. Given that some CDs are already routinely used clinically, and their pharmacokinetic and toxicity profiles are well established, repeating previous encouraging animal studies of HPβCD, this time using HPαCD could lead rapidly to clinical efficacy trials.</p></sec></sec></sec></body><back><ref-list hwp:id="ref-list-1"><title hwp:id="title-43">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Alemayehu M"><surname>Alemayehu</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dragan M"><surname>Dragan</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pape C"><surname>Pape</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title hwp:id="article-title-2">beta-Arrestin2 regulates lysophosphatidic acid-induced human breast tumor cell migration and invasion via Rap1 and IQGAP1</article-title>. <source hwp:id="source-1">PLoS One</source> <volume>8</volume>(<issue>2</issue>): <fpage>e56174</fpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Antalis CJ"><surname>Antalis</surname> <given-names>CJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Uchida A"><surname>Uchida</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Buhman KK"><surname>Buhman</surname> <given-names>KK</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>). <article-title hwp:id="article-title-3">Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification</article-title>. <source hwp:id="source-2">Clin Exp Metastasis</source> <volume>28</volume>(<issue>8</issue>): <fpage>733</fpage>–<lpage>41</lpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Armitage P"><surname>Armitage</surname> <given-names>P</given-names></string-name> (<year>1955</year>). <article-title hwp:id="article-title-4">Tests for linear trends in proportions and frequencies</article-title>. <source hwp:id="source-3">Biometrics</source> <volume>11</volume>(<issue>3</issue>): <fpage>375</fpage>–<lpage>86</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1 xref-ref-4-2 xref-ref-4-3 xref-ref-4-4"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Aslibekyan S"><surname>Aslibekyan</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Claas SA"><surname>Claas</surname> <given-names>SA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Arnett DK"><surname>Arnett</surname> <given-names>DK</given-names></string-name> (<year>2013a</year>). <article-title hwp:id="article-title-5">To replicate or not to replicate: the case of pharmacogenetic studies: Establishing validity of pharmacogenomic findings: from replication to triangulation</article-title>. <source hwp:id="source-4">Circ Cardiovasc Genet</source> <volume>6</volume>(<issue>4</issue>): <fpage>409</fpage>–<lpage>12</lpage>; discussion 12.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Aslibekyan S"><surname>Aslibekyan</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Claas SA"><surname>Claas</surname> <given-names>SA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Arnett DK"><surname>Arnett</surname> <given-names>DK</given-names></string-name> (<year>2013b</year>). <article-title hwp:id="article-title-6">To replicate or not to replicate: the case of pharmacogenetic studies: Have pharmacogenomics failed, or do they just need larger-scale evidence and more replication? - Response to John P.A. Ioannidis, MD, DSc</article-title>. <source hwp:id="source-5">Circ Cardiovasc Genet</source> <volume>6</volume>(<issue>4</issue>): <fpage>418</fpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Badana A"><surname>Badana</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chintala M"><surname>Chintala</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Varikuti G"><surname>Varikuti</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-7">Lipid Raft Integrity Is Required for Survival of Triple Negative Breast Cancer Cells</article-title>. <source hwp:id="source-6">J Breast Cancer</source> <volume>19</volume>(<issue>4</issue>): <fpage>372</fpage>–<lpage>84</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Barsh GS"><surname>Barsh</surname> <given-names>GS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Copenhaver GP"><surname>Copenhaver</surname> <given-names>GP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gibson G"><surname>Gibson</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-8">Guidelines for genome-wide association studies</article-title>. <source hwp:id="source-7">PLoS Genet</source> <volume>8</volume>(<issue>7</issue>): <fpage>e1002812</fpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Belguise K"><surname>Belguise</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Milord S"><surname>Milord</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Galtier F"><surname>Galtier</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-9">The PKCtheta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells</article-title>. <source hwp:id="source-8">Oncogene</source> <volume>31</volume>(<issue>47</issue>): <fpage>4889</fpage>–<lpage>97</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Ben-Chetrit N"><surname>Ben-Chetrit</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chetrit D"><surname>Chetrit</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Russell R"><surname>Russell</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-10">Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer</article-title>. <source hwp:id="source-9">Sci Signal</source> <volume>8</volume>(<issue>360</issue>): <fpage>ra7</fpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Benesch MG"><surname>Benesch</surname> <given-names>MG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tang X"><surname>Tang</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Venkatraman G"><surname>Venkatraman</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-11">Recent advances in targeting the autotaxinlysophosphatidate-lipid phosphate phosphatase axis in vivo</article-title>. <source hwp:id="source-10">J Biomed Res</source> <volume>30</volume>(<issue>4</issue>): <fpage>272</fpage>–<lpage>84</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Bokel C"><surname>Bokel</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brand M"><surname>Brand</surname> <given-names>M</given-names></string-name> (<year>2014</year>). <article-title hwp:id="article-title-12">Endocytosis and signaling during development</article-title>. <source hwp:id="source-11">Cold Spring Harb Perspect Biol</source> <volume>6</volume>(<issue>3</issue>): <fpage>a017020</fpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Bunney TD"><surname>Bunney</surname> <given-names>TD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Katan M"><surname>Katan</surname> <given-names>M</given-names></string-name> (<year>2010</year>). <article-title hwp:id="article-title-13">Phosphoinositide signalling in cancer: beyond PI3K and PTEN</article-title>. <source hwp:id="source-12">Nat Rev Cancer</source> <volume>10</volume>(<issue>5</issue>): <fpage>342</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><citation publication-type="website" citation-type="web" ref:id="152405v2.13" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Burdett T"><surname>Burdett</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hall PN"><surname>Hall</surname> <given-names>PN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hastings E"><surname>Hastings</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <source hwp:id="source-13">The NHGRI-EBI Catalog of published genome-wide association studies</source>. Retrieved 2016-05-16, from <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.ebi.ac.uk/gwas" ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/gwas" hwp:id="ext-link-4">http://www.ebi.ac.uk/gwas</ext-link>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Chen FW"><surname>Chen</surname> <given-names>FW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li C"><surname>Li</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ioannou YA"><surname>Ioannou</surname> <given-names>YA</given-names></string-name> (<year>2010</year>). <article-title hwp:id="article-title-14">Cyclodextrin induces calcium-dependent lysosomal exocytosis</article-title>. <source hwp:id="source-14">PLoS One</source> <volume>5</volume>(<issue>11</issue>): <fpage>e15054</fpage>.</citation></ref><ref id="c15" hwp:id="ref-15" hwp:rev-id="xref-ref-15-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Chen MB"><surname>Chen</surname> <given-names>MB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lamar JM"><surname>Lamar</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li R"><surname>Li</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-15">Elucidation of the Roles of Tumor Integrin beta1 in the Extravasation Stage of the Metastasis Cascade</article-title>. <source hwp:id="source-15">Cancer Res</source> <volume>76</volume>(<issue>9</issue>): <fpage>2513</fpage>–<lpage>24</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Chew CL"><surname>Chew</surname> <given-names>CL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen M"><surname>Chen</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pandolfi PP"><surname>Pandolfi</surname> <given-names>PP</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-16">Endosome and INPP4B</article-title>. <source hwp:id="source-16">Oncotarget</source> <volume>7</volume>(<issue>1</issue>): <fpage>5</fpage>–<lpage>6</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.17" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Chowdhury K"><surname>Chowdhury</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sharma A"><surname>Sharma</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sharma T"><surname>Sharma</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title hwp:id="article-title-17">Simvastatin and MBCD Inhibit Breast Cancer-Induced Osteoclast Activity by Targeting Osteoclastogenic Factors</article-title>. <source hwp:id="source-17">Cancer Invest</source>: <fpage>1</fpage>–<lpage>11</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Cicek MS"><surname>Cicek</surname> <given-names>MS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cunningham JM"><surname>Cunningham</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fridley BL"><surname>Fridley</surname> <given-names>BL</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-18">Colorectal cancer linkage on chromosomes 4 q21,8q13, 12q24, and 15 q22</article-title>. <source hwp:id="source-18">PLoS One</source> <volume>7</volume>(<issue>5</issue>): <fpage>e38175</fpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><collab hwp:id="collab-1">Cochran</collab> (<year>1954</year>). <article-title hwp:id="article-title-19">Some methods of strengthening the commen chi-square tests</article-title>. <source hwp:id="source-19">Biometrics</source> <volume>10</volume>: <fpage>417</fpage>–<lpage>51</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Coffelt SB"><surname>Coffelt</surname> <given-names>SB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wellenstein MD"><surname>Wellenstein</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Visser KE"><surname>de Visser</surname> <given-names>KE</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-20">Neutrophils in cancer: neutral no more</article-title>. <source hwp:id="source-20">Nat Rev Cancer</source> <volume>16</volume>(<issue>7</issue>): <fpage>431</fpage>–<lpage>46</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.21" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Cosker KE"><surname>Cosker</surname> <given-names>KE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Segal RA"><surname>Segal</surname> <given-names>RA</given-names></string-name> (<year>2014</year>). <article-title hwp:id="article-title-21">Neuronal signaling through endocytosis</article-title>. <source hwp:id="source-21">Cold Spring Harb Perspect Biol</source> <volume>6</volume>(<issue>2</issue>): <fpage>a020669</fpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Costa-Silva B"><surname>Costa-Silva</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aiello NM"><surname>Aiello</surname> <given-names>NM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ocean AJ"><surname>Ocean</surname> <given-names>AJ</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-22">Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver</article-title>. <source hwp:id="source-22">Nat Cell Biol</source> <volume>17</volume>(<issue>6</issue>): <fpage>816</fpage>–<lpage>26</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Cronin S"><surname>Cronin</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lin A"><surname>Lin</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thompson K"><surname>Thompson</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-23">Hearing Loss and Otopathology Following Systemic and Intracerebroventricular Delivery of 2 -Hydroxypropyl-Beta-Cyclodextrin</article-title>. <source hwp:id="source-23">J Assoc Res Otolaryngol</source> <volume>16</volume>(<issue>5</issue>): <fpage>599</fpage>–<lpage>611</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Crumling MA"><surname>Crumling</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu L"><surname>Liu</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thomas PV"><surname>Thomas</surname> <given-names>PV</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-24">Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-beta-cyclodextrin</article-title>. <source hwp:id="source-24">PLoS One</source> <volume>7</volume>(<issue>12</issue>): <fpage>e53280</fpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Cui F"><surname>Cui</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu D"><surname>Wu</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang W"><surname>Wang</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-25">Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis</article-title>. <source hwp:id="source-25">Breast Cancer Res Treat</source> <volume>155</volume>(<issue>2</issue>): <fpage>313</fpage>–<lpage>35</lpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Czaplinska D"><surname>Czaplinska</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Turczyk L"><surname>Turczyk</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Grudowska A"><surname>Grudowska</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-26">Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration</article-title>. <source hwp:id="source-26">Biochim Biophys Acta</source> <volume>1843</volume>(<issue>11</issue>): <fpage>2461</fpage>–<lpage>70</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Daleke DL"><surname>Daleke</surname> <given-names>DL</given-names></string-name> (<year>2007</year>). <article-title hwp:id="article-title-27">Phospholipid flippases</article-title>. <source hwp:id="source-27">J Biol Chem</source> <volume>282</volume>(<issue>2</issue>): <fpage>821</fpage>–<lpage>5</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Davidson CD"><surname>Davidson</surname> <given-names>CD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fishman YI"><surname>Fishman</surname> <given-names>YI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Puskas I"><surname>Puskas</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-28">Efficacy and ototoxicity of different cyclodextrins in Niemann-Pick C disease</article-title>. <source hwp:id="source-28">Ann Clin Transl Neurol</source> <volume>3</volume>(<issue>5</issue>): <fpage>366</fpage>–<lpage>80</lpage>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="De Franceschi N"><surname>De Franceschi</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hamidi H"><surname>Hamidi</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alanko J"><surname>Alanko</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-29">Integrin traffic - the update</article-title>. <source hwp:id="source-29">J Cell Sci</source> <volume>128</volume>(<issue>5</issue>): <fpage>839</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Demircioglu F"><surname>Demircioglu</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hodivala-Dilke K"><surname>Hodivala-Dilke</surname> <given-names>K</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-30">alphavbeta3 Integrin and tumour blood vessels-learning from the past to shape the future</article-title>. <source hwp:id="source-30">Curr Opin Cell Biol</source> <volume>42</volume>: <fpage>121</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Donatello S"><surname>Donatello</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Babina IS"><surname>Babina</surname> <given-names>IS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hazelwood LD"><surname>Hazelwood</surname> <given-names>LD</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-31">Lipid raft association restricts CD44-ezrin interaction and promotion of breast cancer cell migration</article-title>. <source hwp:id="source-31">Am J Pathol</source> <volume>181</volume>(<issue>6</issue>): <fpage>2172</fpage>–<lpage>87</lpage>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Dozynkiewicz MA"><surname>Dozynkiewicz</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jamieson NB"><surname>Jamieson</surname> <given-names>NB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Macpherson I"><surname>Macpherson</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-32">Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression</article-title>. <source hwp:id="source-32">Dev Cell</source> <volume>22</volume>(<issue>1</issue>): <fpage>131</fpage>–<lpage>45</lpage>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Emery G"><surname>Emery</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Knoblich JA"><surname>Knoblich</surname> <given-names>JA</given-names></string-name> (<year>2006</year>). <article-title hwp:id="article-title-33">Endosome dynamics during development</article-title>. <source hwp:id="source-33">Curr Opin Cell Biol</source> <volume>18</volume>(<issue>4</issue>): <fpage>407</fpage>–<lpage>15</lpage>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Farge E"><surname>Farge</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ojcius DM"><surname>Ojcius</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Subtil A"><surname>Subtil</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>1999</year>). <article-title hwp:id="article-title-34">Enhancement of endocytosis due to aminophospholipid transport across the plasma membrane of living cells</article-title>. <source hwp:id="source-34">Am J Physiol</source> <volume>276</volume>(<issue>3 Pt 1</issue>): <fpage>C725</fpage>–<lpage>33</lpage>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Fedele C"><surname>Fedele</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Singh A"><surname>Singh</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zerlanko BJ"><surname>Zerlanko</surname> <given-names>BJ</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-35">The alphavbeta6 integrin is transferred intercellularly via exosomes</article-title>. <source hwp:id="source-35">J Biol Chem</source> <volume>290</volume>(<issue>8</issue>): <fpage>4545</fpage>–<lpage>51</lpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Fedida-Metula S"><surname>Fedida-Metula</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Elhyany S"><surname>Elhyany</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tsory S"><surname>Tsory</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2008</year>). <article-title hwp:id="article-title-36">Targeting lipid rafts inhibits protein kinase B by disrupting calcium homeostasis and attenuates malignant properties of melanoma cells</article-title>. <source hwp:id="source-36">Carcinogenesis</source> <volume>29</volume>(<issue>8</issue>): <fpage>1546</fpage>–<lpage>54</lpage>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Frank DW"><surname>Frank</surname> <given-names>DW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gray JE"><surname>Gray</surname> <given-names>JE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weaver RN"><surname>Weaver</surname> <given-names>RN</given-names></string-name> (<year>1976</year>). <article-title hwp:id="article-title-37">Cyclodextrin nephrosis in the rat</article-title>. <source hwp:id="source-37">Am J Pathol</source> <volume>83</volume>(<issue>2</issue>): <fpage>367</fpage>–<lpage>82</lpage>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Frommlet F"><surname>Frommlet</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nuel G"><surname>Nuel</surname> <given-names>G</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-38">An Adaptive Ridge Procedure for L0 Regularization</article-title>. <source hwp:id="source-38">PLoS One</source> <volume>11</volume>(<issue>2</issue>): <fpage>e0148620</fpage>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Garcia-Closas M"><surname>Garcia-Closas</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Couch FJ"><surname>Couch</surname> <given-names>FJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lindstrom S"><surname>Lindstrom</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title hwp:id="article-title-39">Genome-wide association studies identify four ER negative-specific breast cancer risk loci</article-title>. <source hwp:id="source-39">Nat Genet</source> <volume>45</volume>(<issue>4</issue>): <fpage>392</fpage>–<lpage>8</lpage>, 8 e1-2.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Goetz JG"><surname>Goetz</surname> <given-names>JG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Minguet S"><surname>Minguet</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Navarro-Lerida I"><surname>Navarro-Lerida</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>). <article-title hwp:id="article-title-40">Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis</article-title>. <source hwp:id="source-40">Cell</source> <volume>146</volume>(<issue>1</issue>): <fpage>148</fpage>–<lpage>63</lpage>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1 xref-ref-41-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Gotoh K"><surname>Gotoh</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kariya R"><surname>Kariya</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alam MM"><surname>Alam</surname> <given-names>MM</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-41">The antitumor effects of methyl-beta-cyclodextrin against primary effusion lymphoma via the depletion of cholesterol from lipid rafts</article-title>. <source hwp:id="source-41">Biochem Biophys Res Commun</source> <volume>455</volume>(<issue>3–4</issue>): <fpage>285</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Gould S"><surname>Gould</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Scott RC"><surname>Scott</surname> <given-names>RC</given-names></string-name> (<year>2005</year>). <article-title hwp:id="article-title-42">2 -Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review</article-title>. <source hwp:id="source-42">Food Chem Toxicol</source> <volume>43</volume>(<issue>10</issue>): <fpage>1451</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Grosse PY"><surname>Grosse</surname> <given-names>PY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bressolle F"><surname>Bressolle</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pinguet F"><surname>Pinguet</surname> <given-names>F</given-names></string-name> (<year>1998</year>). <article-title hwp:id="article-title-43">Antiproliferative effect of methyl-beta-cyclodextrin in vitro and in human tumour xenografted athymic nude mice</article-title>. <source hwp:id="source-43">Br J Cancer</source> <volume>78</volume>(<issue>9</issue>): <fpage>1165</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1 xref-ref-44-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Guerra FS"><surname>Guerra</surname> <given-names>FS</given-names></string-name>, <string-name name-style="western" hwp:sortable="LdS Sampaio"><given-names>Sampaio</given-names> <surname>LdS</surname></string-name>, <string-name name-style="western" hwp:sortable="Konig S"><surname>Konig</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-44">Membrane cholesterol depletion reduces breast tumor cell migration by a mechanism that involves non-canonical Wnt signaling and IL-10 secretion</article-title>. <source hwp:id="source-44">Translational Medicine Communications</source> <volume>1</volume>(<issue>1</issue>): <fpage>3</fpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Guglielmi L"><surname>Guglielmi</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Servettini I"><surname>Servettini</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Caramia M"><surname>Caramia</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-45">Update on the implication of potassium channels in autism: K(+) channelautism spectrum disorder</article-title>. <source hwp:id="source-45">Front Cell Neurosci</source> <volume>9</volume>: <fpage>34</fpage>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Haibe-Kains B"><surname>Haibe-Kains</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Desmedt C"><surname>Desmedt</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Piette F"><surname>Piette</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal> (<year>2008</year>). <article-title hwp:id="article-title-46">Comparison of prognostic gene expression signatures for breast cancer</article-title>. <source hwp:id="source-46">BMC Genomics</source> <volume>9</volume>: <fpage>394</fpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Haiman CA"><surname>Haiman</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen GK"><surname>Chen</surname> <given-names>GK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vachon CM"><surname>Vachon</surname> <given-names>CM</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>). <article-title hwp:id="article-title-47">A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer</article-title>. <source hwp:id="source-47">Nat Genet</source> <volume>43</volume>(<issue>12</issue>): <fpage>1210</fpage>–<lpage>4</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><citation publication-type="book" citation-type="book" ref:id="152405v2.48" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Hajek J"><surname>Hajek</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sidak Z"><surname>Sidak</surname> <given-names>Z</given-names></string-name> (<year>1967</year>). <source hwp:id="source-48">Theory of rank tests</source>. <publisher-name>New York, NY, Academic</publisher-name>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Hall DP"><surname>Hall</surname> <given-names>DP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cost NG"><surname>Cost</surname> <given-names>NG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hegde S"><surname>Hegde</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-48">TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinoma</article-title>. <source hwp:id="source-49">Cancer cell</source> <volume>26</volume>(<issue>5</issue>): <fpage>738</fpage>–<lpage>53</lpage>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Hanna S"><surname>Hanna</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Khalil B"><surname>Khalil</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nasrallah A"><surname>Nasrallah</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-49">StarD13 is a tumor suppressor in breast cancer that regulates cell motility and invasion</article-title>. <source hwp:id="source-50">Int J Oncol</source> <volume>44</volume>(<issue>5</issue>): <fpage>1499</fpage>–<lpage>511</lpage>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Harris DA"><surname>Harris</surname> <given-names>DA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patel SH"><surname>Patel</surname> <given-names>SH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gucek M"><surname>Gucek</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-50">Exosomes released from breast cancer carcinomas stimulate cell movement</article-title>. <source hwp:id="source-51">PLoS One</source> <volume>10</volume>(<issue>3</issue>): <fpage>e0117495</fpage>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1 xref-ref-52-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Hashimoto S"><surname>Hashimoto</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mikami S"><surname>Mikami</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sugino H"><surname>Sugino</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-51">Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer</article-title>. <source hwp:id="source-52">Nat Commun</source> <volume>7</volume>: <fpage>10656</fpage>.</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><citation publication-type="website" citation-type="web" ref:id="152405v2.53" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Hastings C."><surname>Hastings</surname> <given-names>C.</given-names></string-name> (<year>2009</year>). <article-title hwp:id="article-title-52">Addi and Cassi Hydroxy-Propyl-Beta-Cyclodextrin Plan</article-title>. <source hwp:id="source-53">Compassionate Use Clinical Study</source>. Treatment Plan Version #2. Retrieved 2016-11-13, from <ext-link l:rel="related" l:ref-type="uri" l:ref="http://addiandcassi.com/wordpress/wpcontent/uploads/2009/09/FDA-Submission-for-Addi-and-Cassi-Cyclodextrin-Treatment-Plan.pdf" ext-link-type="uri" xlink:href="http://addiandcassi.com/wordpress/wpcontent/uploads/2009/09/FDA-Submission-for-Addi-and-Cassi-Cyclodextrin-Treatment-Plan.pdf" hwp:id="ext-link-5">http://addiandcassi.com/wordpress/wpcontent/uploads/2009/09/FDA-Submission-for-Addi-and-Cassi-Cyclodextrin-Treatment-Plan.pdf</ext-link>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Hayashi S"><surname>Hayashi</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kimura M"><surname>Kimura</surname> <given-names>M</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-53">Mechanisms of hormonal therapy resistance in breast cancer</article-title>. <source hwp:id="source-54">Int J Clin Oncol</source> <volume>20</volume>(<issue>2</issue>): <fpage>262</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Heusermann W"><surname>Heusermann</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hean J"><surname>Hean</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trojer D"><surname>Trojer</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-54">Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER</article-title>. <source hwp:id="source-55">J Cell Biol</source> <volume>213</volume>(<issue>2</issue>): <fpage>173</fpage>–<lpage>84</lpage>.</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.56" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-56"><string-name name-style="western" hwp:sortable="Hoeffding W"><surname>Hoeffding</surname> <given-names>W</given-names></string-name> (<year>1948</year>). <article-title hwp:id="article-title-55">A Class of Statistics with Asymptotically Normal Distribution</article-title>. <source hwp:id="source-56">Ann Math Stat</source> <volume>19</volume>(<issue>3</issue>):<fpage>293</fpage>–<lpage>325</lpage>.</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1 xref-ref-57-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.57" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-57"><string-name name-style="western" hwp:sortable="Hoffman JD"><surname>Hoffman</surname> <given-names>JD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Graff RE"><surname>Graff</surname> <given-names>RE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Emami NC"><surname>Emami</surname> <given-names>NC</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title hwp:id="article-title-56">Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk</article-title>. <source hwp:id="source-57">PLoS Genet</source> <volume>13</volume>(<issue>3</issue>): <fpage>e1006690</fpage>.</citation></ref><ref id="c58" hwp:id="ref-58" hwp:rev-id="xref-ref-58-1 xref-ref-58-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.58" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-58"><string-name name-style="western" hwp:sortable="Hoshino A"><surname>Hoshino</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Costa-Silva B"><surname>Costa-Silva</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shen T-L"><surname>Shen</surname> <given-names>T-L</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-57">Tumour exosome integrins determine organotropic metastasis</article-title>. <source hwp:id="source-58">Nature</source> <volume>527</volume>(<issue>7578</issue>): <fpage>329</fpage>–<lpage>35</lpage>.</citation></ref><ref id="c59" hwp:id="ref-59" hwp:rev-id="xref-ref-59-1 xref-ref-59-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.59" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-59"><string-name name-style="western" hwp:sortable="Hunter DJ"><surname>Hunter</surname> <given-names>DJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kraft P"><surname>Kraft</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jacobs KB"><surname>Jacobs</surname> <given-names>KB</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title hwp:id="article-title-58">A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer</article-title>. <source hwp:id="source-59">Nature Genet</source> <volume>39</volume>(<issue>7</issue>): <fpage>870</fpage>–<lpage>4</lpage>.</citation></ref><ref id="c60" hwp:id="ref-60" hwp:rev-id="xref-ref-60-1 xref-ref-60-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.60" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-60"><string-name name-style="western" hwp:sortable="Ioannidis JP"><surname>Ioannidis</surname> <given-names>JP</given-names></string-name> (<year>2013</year>). <article-title hwp:id="article-title-59">To replicate or not to replicate: the case of pharmacogenetic studies: Have pharmacogenomics failed, or do they just need larger-scale evidence and more replication?</article-title> <source hwp:id="source-60">Circ Cardiovasc Genet</source> <volume>6</volume>(<issue>4</issue>): <fpage>413</fpage>–<lpage>8</lpage>; discussion 8.</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.61" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="Ioannidis JP"><surname>Ioannidis</surname> <given-names>JP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thomas G"><surname>Thomas</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Daly MJ"><surname>Daly</surname> <given-names>MJ</given-names></string-name> (<year>2009</year>). <article-title hwp:id="article-title-60">Validating, augmenting and refining genome-wide association signals</article-title>. <source hwp:id="source-61">Nat Rev Genet</source> <volume>10</volume>(<issue>5</issue>): <fpage>318</fpage>–<lpage>29</lpage>.</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><string-name name-style="western" hwp:sortable="Iyer MK"><surname>Iyer</surname> <given-names>MK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Niknafs YS"><surname>Niknafs</surname> <given-names>YS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Malik R"><surname>Malik</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-61">The landscape of long noncoding RNAs in the human transcriptome</article-title>. <source hwp:id="source-62">Nat Genet</source> <volume>47</volume>(<issue>3</issue>): <fpage>199</fpage>–<lpage>208</lpage>.</citation></ref><ref id="c63" hwp:id="ref-63" hwp:rev-id="xref-ref-63-1 xref-ref-63-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="Kamar RI"><surname>Kamar</surname> <given-names>RI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Organ-Darling LE"><surname>Organ-Darling</surname> <given-names>LE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raphael RM"><surname>Raphael</surname> <given-names>RM</given-names></string-name> (<year>2012</year>). <article-title hwp:id="article-title-62">Membrane Cholesterol Strongly Influences Confined Diffusion of Prestin</article-title>. <source hwp:id="source-63">Biophysical Journal</source> <volume>103</volume>(<issue>8</issue>): <fpage>1627</fpage>–<lpage>36</lpage>.</citation></ref><ref id="c64" hwp:id="ref-64" hwp:rev-id="xref-ref-64-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="Kawauchi T"><surname>Kawauchi</surname> <given-names>T</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-63">Cellullar insights into cerebral cortical development: focusing on the locomotion mode of neuronal migration</article-title>. <source hwp:id="source-64">Front Cell Neurosci</source> <volume>9</volume>: <fpage>394</fpage>.</citation></ref><ref id="c65" hwp:id="ref-65" hwp:rev-id="xref-ref-65-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.65" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Keerthikumar S"><surname>Keerthikumar</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gangoda L"><surname>Gangoda</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liem M"><surname>Liem</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-64">Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes</article-title>. <source hwp:id="source-65">Oncotarget</source> <volume>6</volume>(<issue>17</issue>): <fpage>15375</fpage>–<lpage>96</lpage>.</citation></ref><ref id="c66" hwp:id="ref-66" hwp:rev-id="xref-ref-66-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Kendellen MF"><surname>Kendellen</surname> <given-names>MF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bradford JW"><surname>Bradford</surname> <given-names>JW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lawrence CL"><surname>Lawrence</surname> <given-names>CL</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-65">Canonical and non-canonical NF-kappaB signaling promotes breast cancer tumor-initiating cells</article-title>. <source hwp:id="source-66">Oncogene</source> <volume>33</volume>(<issue>10</issue>): <fpage>1297</fpage>–<lpage>305</lpage>.</citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Kerr WG"><surname>Kerr</surname> <given-names>WG</given-names></string-name> (<year>2011</year>). <article-title hwp:id="article-title-66">Inhibitor and activator: dual functions for SHIP in immunity and cancer</article-title>. <source hwp:id="source-67">Ann N Y Acad Sci</source> <volume>1217</volume>: <fpage>1</fpage>–<lpage>17</lpage>.</citation></ref><ref id="c68" hwp:id="ref-68" hwp:rev-id="xref-ref-68-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.68" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-68"><string-name name-style="western" hwp:sortable="Klein RJ"><surname>Klein</surname> <given-names>RJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zeiss C"><surname>Zeiss</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chew EY"><surname>Chew</surname> <given-names>EY</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>). <article-title hwp:id="article-title-67">Complement factor H polymorphism in age-related macular degeneration</article-title>. <source hwp:id="source-68">Science</source> <volume>308</volume>(<issue>5720</issue>): <fpage>385</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c69" hwp:id="ref-69" hwp:rev-id="xref-ref-69-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.69" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-69"><string-name name-style="western" hwp:sortable="Koumangoye RB"><surname>Koumangoye</surname> <given-names>RB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sakwe AM"><surname>Sakwe</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goodwin JS"><surname>Goodwin</surname> <given-names>JS</given-names></string-name>, <etal>et al.</etal> (<year>2011</year>). <article-title hwp:id="article-title-68">Detachment of Breast Tumor Cells Induces Rapid Secretion of Exosomes Which Subsequently Mediate Cellular Adhesion and Spreading</article-title>. <source hwp:id="source-69">PLoS One</source> <volume>6</volume>(<issue>9</issue>): <fpage>e24234</fpage>.</citation></ref><ref id="c70" hwp:id="ref-70" hwp:rev-id="xref-ref-70-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.70" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-70"><string-name name-style="western" hwp:sortable="Kruskal WH"><surname>Kruskal</surname> <given-names>WH</given-names></string-name> (<year>1957</year>). <article-title hwp:id="article-title-69">Historical notes on the Wilcoxon unpaired two-sample test</article-title>. <source hwp:id="source-70">J Am Statist Assoc</source> <volume>52</volume>:<fpage>356</fpage>–<lpage>60</lpage>.</citation></ref><ref id="c71" hwp:id="ref-71" hwp:rev-id="xref-ref-71-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.71" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-71"><string-name name-style="western" hwp:sortable="Lagace TA"><surname>Lagace</surname> <given-names>TA</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-70">Phosphatidylcholine: Greasing the Cholesterol Transport Machinery</article-title>. <source hwp:id="source-71">Lipid insights</source> <volume>8</volume>(<issue>Suppl 1</issue>): <fpage>65</fpage>–<lpage>73</lpage>.</citation></ref><ref id="c72" hwp:id="ref-72" hwp:rev-id="xref-ref-72-1 xref-ref-72-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.72" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-72"><string-name name-style="western" hwp:sortable="Leca J"><surname>Leca</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Martinez S"><surname>Martinez</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lac S"><surname>Lac</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-71">Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness</article-title>. <source hwp:id="source-72">J Clin Invest</source> <volume>126</volume>(<issue>11</issue>): <fpage>4140</fpage>–<lpage>56</lpage>.</citation></ref><ref id="c73" hwp:id="ref-73" hwp:rev-id="xref-ref-73-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.73" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-73"><string-name name-style="western" hwp:sortable="Leroy-Lechat F"><surname>Leroy-Lechat</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wouessidjewe D"><surname>Wouessidjewe</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Andreux JP"><surname>Andreux</surname> <given-names>JP</given-names></string-name>, <etal>et al.</etal> (<year>1994</year>). <article-title hwp:id="article-title-72">Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivatives</article-title>. <source hwp:id="source-73">International Journal of Pharmaceutics</source> <volume>101</volume>(<issue>1–2</issue>): <fpage>97</fpage>–<lpage>103</lpage>.</citation></ref><ref id="c74" hwp:id="ref-74" hwp:rev-id="xref-ref-74-1 xref-ref-74-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.74" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-74"><string-name name-style="western" hwp:sortable="Li H"><surname>Li</surname> <given-names>H</given-names></string-name> (<year>2012</year>). <article-title hwp:id="article-title-73">U-statistics in genetic association studies</article-title>. <source hwp:id="source-74">Hum Genet</source> <volume>131</volume>(<issue>9</issue>): <fpage>1395</fpage>–<lpage>401</lpage>.</citation></ref><ref id="c75" hwp:id="ref-75"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.75" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-75"><string-name name-style="western" hwp:sortable="Li J"><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ballif BA"><surname>Ballif</surname> <given-names>BA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Powelka AM"><surname>Powelka</surname> <given-names>AM</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>). <article-title hwp:id="article-title-74">Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration</article-title>. <source hwp:id="source-75">Dev Cell</source> <volume>9</volume>(<issue>5</issue>): <fpage>663</fpage>–<lpage>73</lpage>.</citation></ref><ref id="c76" hwp:id="ref-76" hwp:rev-id="xref-ref-76-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.76" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-76"><string-name name-style="western" hwp:sortable="Li J"><surname>Li</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yen C"><surname>Yen</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liaw D"><surname>Liaw</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> (<year>1997</year>). <article-title hwp:id="article-title-75">PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer</article-title>. <source hwp:id="source-76">Science</source> <volume>275</volume>(<issue>5308</issue>): <fpage>1943</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c77" hwp:id="ref-77" hwp:rev-id="xref-ref-77-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.77" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-77"><string-name name-style="western" hwp:sortable="Li YC"><surname>Li</surname> <given-names>YC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Park MJ"><surname>Park</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ye SK"><surname>Ye</surname> <given-names>SK</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>). <article-title hwp:id="article-title-76">Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents</article-title>. <source hwp:id="source-77">Am J Pathol</source> <volume>168</volume>(<issue>4</issue>): <fpage>1107</fpage>–<lpage>18</lpage>; quiz 404-5.</citation></ref><ref id="c78" hwp:id="ref-78" hwp:rev-id="xref-ref-78-1"><citation publication-type="other" citation-type="journal" ref:id="152405v2.78" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-78"><string-name name-style="western" hwp:sortable="Liu W"><surname>Liu</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li T"><surname>Li</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang P"><surname>Wang</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title hwp:id="article-title-77">LRRC25 plays a key role in all-trans retinoic acid-induced granulocytic differentiation as a novel potential leukocyte differentiation antigen</article-title>. <source hwp:id="source-78">Protein Cell</source>.</citation></ref><ref id="c79" hwp:id="ref-79" hwp:rev-id="xref-ref-79-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.79" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-79"><string-name name-style="western" hwp:sortable="Liu Y"><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sun R"><surname>Sun</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wan W"><surname>Wan</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title hwp:id="article-title-78">The involvement of lipid rafts in epidermal growth factor-induced chemotaxis of breast cancer cells</article-title>. <source hwp:id="source-79">Molecular membrane biology</source> <volume>24</volume>(<issue>2</issue>): <fpage>91</fpage>–<lpage>101</lpage>.</citation></ref><ref id="c80" hwp:id="ref-80" hwp:rev-id="xref-ref-80-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.80" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-80"><string-name name-style="western" hwp:sortable="Loftsson T"><surname>Loftsson</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brewster ME"><surname>Brewster</surname> <given-names>ME</given-names></string-name> (<year>2010</year>). <article-title hwp:id="article-title-79">Pharmaceutical applications of cyclodextrins: basic science and product development</article-title>. <source hwp:id="source-80">J Pharm Pharmacol</source> <volume>62</volume>(<issue>11</issue>): <fpage>1607</fpage>–<lpage>21</lpage>.</citation></ref><ref id="c81" hwp:id="ref-81" hwp:rev-id="xref-ref-81-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.81" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-81"><string-name name-style="western" hwp:sortable="Lowry MC"><surname>Lowry</surname> <given-names>MC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gallagher WM"><surname>Gallagher</surname> <given-names>WM</given-names></string-name>, <string-name name-style="western" hwp:sortable="O'Driscoll L"><surname>O'Driscoll</surname> <given-names>L</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-80">The Role of Exosomes in Breast Cancer</article-title>. <source hwp:id="source-81">Clin Chem</source> <volume>61</volume>(<issue>12</issue>): <fpage>1457</fpage>–<lpage>65</lpage>.</citation></ref><ref id="c82" hwp:id="ref-82" hwp:rev-id="xref-ref-82-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.82" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-82"><string-name name-style="western" hwp:sortable="Maarup TJ"><surname>Maarup</surname> <given-names>TJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen AH"><surname>Chen</surname> <given-names>AH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Porter FD"><surname>Porter</surname> <given-names>FD</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-81">Intrathecal 2 -hydroxypropyl-beta-cyclodextrin in a single patient with Niemann-Pick C1</article-title>. <source hwp:id="source-82">Mol Genet Metab</source> <volume>116</volume>(<issue>1-2</issue>): <fpage>75</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c83" hwp:id="ref-83" hwp:rev-id="xref-ref-83-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.83" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-83"><string-name name-style="western" hwp:sortable="Machiela MJ"><surname>Machiela</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chanock SJ"><surname>Chanock</surname> <given-names>SJ</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-82">LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants</article-title>. <source hwp:id="source-83">Bioinformatics</source> <volume>31</volume>(<issue>21</issue>): <fpage>3555</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c84" hwp:id="ref-84" hwp:rev-id="xref-ref-84-1 xref-ref-84-2 xref-ref-84-3"><citation publication-type="other" citation-type="journal" ref:id="152405v2.84" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-84"><string-name name-style="western" hwp:sortable="Maji S"><surname>Maji</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chaudhary P"><surname>Chaudhary</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Akopova I"><surname>Akopova</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-83">Exosomal Annexin A2 Promotes Angiogenesis and Breast Cancer Metastasis</article-title>. <source hwp:id="source-84">Mol Cancer Res</source>.</citation></ref><ref id="c85" hwp:id="ref-85" hwp:rev-id="xref-ref-85-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.85" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-85"><string-name name-style="western" hwp:sortable="Mann HB"><surname>Mann</surname> <given-names>HB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Whitney DR"><surname>Whitney</surname> <given-names>DR</given-names></string-name> (<year>1947</year>). <article-title hwp:id="article-title-84">On a test of whether one of two random variables is stochastically larger than the other</article-title>. <source hwp:id="source-85">Ann Math Stat</source> <volume>18</volume>(<issue>1</issue>): <fpage>50</fpage>–<lpage>60</lpage>.</citation></ref><ref id="c86" hwp:id="ref-86" hwp:rev-id="xref-ref-86-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.86" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-86"><string-name name-style="western" hwp:sortable="McNamara CR"><surname>McNamara</surname> <given-names>CR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Degterev A"><surname>Degterev</surname> <given-names>A</given-names></string-name> (<year>2011</year>). <article-title hwp:id="article-title-85">Small-molecule inhibitors of the PI3K signaling network</article-title>. <source hwp:id="source-86">Future medicinal chemistry</source> <volume>3</volume>(<issue>5</issue>): <fpage>549</fpage>–<lpage>65</lpage>.</citation></ref><ref id="c87" hwp:id="ref-87" hwp:rev-id="xref-ref-87-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.87" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-87"><string-name name-style="western" hwp:sortable="Menard JA"><surname>Menard</surname> <given-names>JA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Christianson HC"><surname>Christianson</surname> <given-names>HC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kucharzewska P"><surname>Kucharzewska</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-86">Metastasis Stimulation by Hypoxia and Acidosis-Induced Extracellular Lipid Uptake Is Mediated by Proteoglycan-Dependent Endocytosis</article-title>. <source hwp:id="source-87">Cancer Res</source> <volume>76</volume>(<issue>16</issue>): <fpage>4828</fpage>–<lpage>40</lpage>.</citation></ref><ref id="c88" hwp:id="ref-88" hwp:rev-id="xref-ref-88-1 xref-ref-88-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.88" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-88"><string-name name-style="western" hwp:sortable="Michailidou K"><surname>Michailidou</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hall P"><surname>Hall</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gonzalez-Neira A"><surname>Gonzalez-Neira</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title hwp:id="article-title-87">Large-scale genotyping identifies 41 new loci associated with breast cancer risk</article-title>. <source hwp:id="source-88">Nat Genet</source> <volume>45</volume>(<issue>4</issue>): <fpage>353</fpage>–<lpage>61</lpage>, 61 e1-2.</citation></ref><ref id="c89" hwp:id="ref-89" hwp:rev-id="xref-ref-89-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.89" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-89"><string-name name-style="western" hwp:sortable="Mills GB"><surname>Mills</surname> <given-names>GB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moolenaar WH"><surname>Moolenaar</surname> <given-names>WH</given-names></string-name> (<year>2003</year>). <article-title hwp:id="article-title-88">The emerging role of lysophosphatidic acid in cancer</article-title>. <source hwp:id="source-89">Nat Rev Cancer</source> <volume>3</volume>(<issue>8</issue>): <fpage>582</fpage>–<lpage>91</lpage>.</citation></ref><ref id="c90" hwp:id="ref-90" hwp:rev-id="xref-ref-90-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.90" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-90"><string-name name-style="western" hwp:sortable="Mitra S"><surname>Mitra</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Federico L"><surname>Federico</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhao W"><surname>Zhao</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-89">Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT</article-title>. <source hwp:id="source-90">Oncotarget</source> <volume>7</volume>(<issue>26</issue>): <fpage>40252</fpage>–<lpage>65</lpage>.</citation></ref><ref id="c91" hwp:id="ref-91" hwp:rev-id="xref-ref-91-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.91" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-91"><string-name name-style="western" hwp:sortable="Mohamad Fairus AK"><surname>Mohamad Fairus</surname> <given-names>AK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Choudhary B"><surname>Choudhary</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hosahalli S"><surname>Hosahalli</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title hwp:id="article-title-90">Dihydroorotate dehydrogenase (DHODH) inhibitors affect ATP depletion, endogenous ROS and mediate S-phase arrest in breast cancer cells</article-title>. <source hwp:id="source-91">Biochimie</source> <volume>135</volume>: <fpage>154</fpage>–<lpage>63</lpage>.</citation></ref><ref id="c92" hwp:id="ref-92" hwp:rev-id="xref-ref-92-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.92" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-92"><string-name name-style="western" hwp:sortable="Morgan MR"><surname>Morgan</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Byron A"><surname>Byron</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Humphries MJ"><surname>Humphries</surname> <given-names>MJ</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title hwp:id="article-title-91">Giving off mixed signals--distinct functions of alpha5beta1 and alphavbeta3 integrins in regulating cell behaviour</article-title>. <source hwp:id="source-92">IUBMB Life</source> <volume>61</volume>(<issue>7</issue>): <fpage>731</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c93" hwp:id="ref-93" hwp:rev-id="xref-ref-93-1 xref-ref-93-2 xref-ref-93-3 xref-ref-93-4 xref-ref-93-5"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.93" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-93"><string-name name-style="western" hwp:sortable="Mosesson Y"><surname>Mosesson</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mills GB"><surname>Mills</surname> <given-names>GB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yarden Y"><surname>Yarden</surname> <given-names>Y</given-names></string-name> (<year>2008</year>). <article-title hwp:id="article-title-92">Derailed endocytosis: an emerging feature of cancer</article-title>. <source hwp:id="source-93">Nat Rev Cancer</source> <volume>8</volume>(<issue>11</issue>): <fpage>835</fpage>–<lpage>50</lpage>.</citation></ref><ref id="c94" hwp:id="ref-94" hwp:rev-id="xref-ref-94-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.94" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-94"><string-name name-style="western" hwp:sortable="Mussunoor S"><surname>Mussunoor</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Murray GI"><surname>Murray</surname> <given-names>GI</given-names></string-name> (<year>2008</year>). <article-title hwp:id="article-title-93">The role of annexins in tumour development and progression</article-title>. <source hwp:id="source-94">J Pathol</source> <volume>216</volume>(<issue>2</issue>): <fpage>131</fpage>–<lpage>40</lpage>.</citation></ref><ref id="c95" hwp:id="ref-95" hwp:rev-id="xref-ref-95-1 xref-ref-95-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.95" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-95"><string-name name-style="western" hwp:sortable="Ohtani Y"><surname>Ohtani</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Irie T"><surname>Irie</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Uekama K"><surname>Uekama</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> (<year>1989</year>). <article-title hwp:id="article-title-94">Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes</article-title>. <source hwp:id="source-95">European Journal of Biochemistry</source> <volume>186</volume>(<issue>1–2</issue>): <fpage>17</fpage>–<lpage>22</lpage>.</citation></ref><ref id="c96" hwp:id="ref-96" hwp:rev-id="xref-ref-96-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.96" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-96"><string-name name-style="western" hwp:sortable="Ostrowski M"><surname>Ostrowski</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carmo NB"><surname>Carmo</surname> <given-names>NB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Krumeich S"><surname>Krumeich</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title hwp:id="article-title-95">Rab27a and Rab27b control different steps of the exosome secretion pathway</article-title>. <source hwp:id="source-96">Nat Cell Biol</source> <volume>12</volume>(<issue>1</issue>): <fpage>19</fpage>–<lpage>30</lpage>; sup pp 1-13.</citation></ref><ref id="c97" hwp:id="ref-97" hwp:rev-id="xref-ref-97-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.97" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-97"><string-name name-style="western" hwp:sortable="Palaniyandi K"><surname>Palaniyandi</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pockaj BA"><surname>Pockaj</surname> <given-names>BA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gendler SJ"><surname>Gendler</surname> <given-names>SJ</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-96">Human Breast Cancer Stem Cells Have Significantly Higher Rate of Clathrin-Independent and Caveolin-Independent Endocytosis than the Differentiated Breast Cancer Cells</article-title>. <source hwp:id="source-97">Journal of cancer science&amp; therapy</source> <volume>4</volume>(<issue>7</issue>): <fpage>214</fpage>–<lpage>22</lpage>.</citation></ref><ref id="c98" hwp:id="ref-98" hwp:rev-id="xref-ref-98-1 xref-ref-98-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.98" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-98"><string-name name-style="western" hwp:sortable="Panagiotou OA"><surname>Panagiotou</surname> <given-names>OA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ioannidis JPA"><surname>Ioannidis</surname> <given-names>JPA</given-names></string-name>, <string-name name-style="western" hwp:sortable="ftG-WS Project"><given-names>Project</given-names> <surname>ftG-WS</surname></string-name> (<year>2012</year>). <article-title hwp:id="article-title-97">What should the genome-wide significance threshold be? Empirical replication of borderline genetic associations</article-title>. <source hwp:id="source-98">International Journal of Epidemiology</source> <volume>41</volume>(<issue>1</issue>): <fpage>273</fpage>–<lpage>86</lpage>.</citation></ref><ref id="c99" hwp:id="ref-99" hwp:rev-id="xref-ref-99-1 xref-ref-99-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.99" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-99"><string-name name-style="western" hwp:sortable="Pearson TA"><surname>Pearson</surname> <given-names>TA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Manolio TA"><surname>Manolio</surname> <given-names>TA</given-names></string-name> (<year>2008</year>). <article-title hwp:id="article-title-98">How to interpret a genome-wide association study</article-title>. <source hwp:id="source-99">JAMA</source> <volume>299</volume>(<issue>11</issue>): <fpage>1335</fpage>–<lpage>44</lpage>.</citation></ref><ref id="c100" hwp:id="ref-100" hwp:rev-id="xref-ref-100-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.100" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-100"><string-name name-style="western" hwp:sortable="Peinado H"><surname>Peinado</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aleckovic M"><surname>Aleckovic</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lavotshkin S"><surname>Lavotshkin</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-99">Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET</article-title>. <source hwp:id="source-100">Nat Med</source> <volume>18</volume>(<issue>6</issue>): <fpage>883</fpage>–<lpage>91</lpage>.</citation></ref><ref id="c101" hwp:id="ref-101" hwp:rev-id="xref-ref-101-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.101" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-101"><string-name name-style="western" hwp:sortable="Peinado H"><surname>Peinado</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lavotshkin S"><surname>Lavotshkin</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lyden D"><surname>Lyden</surname> <given-names>D</given-names></string-name> (<year>2011</year>). <article-title hwp:id="article-title-100">The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts</article-title>. <source hwp:id="source-101">Semin Cancer Biol</source> <volume>21</volume>(<issue>2</issue>): <fpage>139</fpage>–<lpage>46</lpage>.</citation></ref><ref id="c102" hwp:id="ref-102" hwp:rev-id="xref-ref-102-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.102" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-102"><string-name name-style="western" hwp:sortable="Peng G"><surname>Peng</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Luo L"><surname>Luo</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Siu H"><surname>Siu</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title hwp:id="article-title-101">Gene and pathway-based second-wave analysis of genome-wide association studies</article-title>. <source hwp:id="source-102">Eur J Hum Genet</source> <volume>18</volume>(<issue>1</issue>): <fpage>111</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c103" hwp:id="ref-103" hwp:rev-id="xref-ref-103-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.103" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-103"><string-name name-style="western" hwp:sortable="Pickrell JK"><surname>Pickrell</surname> <given-names>JK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Berisa T"><surname>Berisa</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu JZ"><surname>Liu</surname> <given-names>JZ</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-102">Detection and interpretation of shared genetic influences on 42 human traits</article-title>. <source hwp:id="source-103">Nat Genet</source> <volume>48</volume>(<issue>7</issue>): <fpage>709</fpage>–<lpage>17</lpage>.</citation></ref><ref id="c104" hwp:id="ref-104" hwp:rev-id="xref-ref-104-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.104" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-104"><string-name name-style="western" hwp:sortable="Posor Y"><surname>Posor</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eichhorn-Grunig M"><surname>Eichhorn-Grunig</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Haucke V"><surname>Haucke</surname> <given-names>V</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-103">Phosphoinositides in endocytosis</article-title>. <source hwp:id="source-104">Biochim Biophys Acta</source> <volume>1851</volume>(<issue>6</issue>): <fpage>794</fpage>–<lpage>804</lpage>.</citation></ref><ref id="c105" hwp:id="ref-105" hwp:rev-id="xref-ref-105-1 xref-ref-105-2 xref-ref-105-3"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.105" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-105"><string-name name-style="western" hwp:sortable="Powis G"><surname>Powis</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Berggren M"><surname>Berggren</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gallegos A"><surname>Gallegos</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>1995</year>). <article-title hwp:id="article-title-104">Advances with phospholipid signalling as a target for anticancer drug development</article-title>. <source hwp:id="source-105">Acta Biochim Pol</source> <volume>42</volume>(<issue>4</issue>): <fpage>395</fpage>–<lpage>403</lpage>.</citation></ref><ref id="c106" hwp:id="ref-106" hwp:rev-id="xref-ref-106-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.106" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-106"><string-name name-style="western" hwp:sortable="Raghu H"><surname>Raghu</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sodadasu PK"><surname>Sodadasu</surname> <given-names>PK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Malla RR"><surname>Malla</surname> <given-names>RR</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title hwp:id="article-title-105">Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells</article-title>. <source hwp:id="source-106">BMC Cancer</source> <volume>10</volume>: <fpage>647</fpage>.</citation></ref><ref id="c107" hwp:id="ref-107" hwp:rev-id="xref-ref-107-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.107" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-107"><string-name name-style="western" hwp:sortable="Rajnavolgyi E"><surname>Rajnavolgyi</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Laczik R"><surname>Laczik</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kun V"><surname>Kun</surname> <given-names>V</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <source hwp:id="source-107">Effects of RAMEA-complexed polyunsaturated fatty acids on the response of human dendritic cells to inflammatory signals. Beilstein J Org Chem</source> <volume>10</volume>: <fpage>3152</fpage>–<lpage>60</lpage>.</citation></ref><ref id="c108" hwp:id="ref-108" hwp:rev-id="xref-ref-108-1 xref-ref-108-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.108" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-108"><string-name name-style="western" hwp:sortable="Ratajczak MZ"><surname>Ratajczak</surname> <given-names>MZ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Suszynska M"><surname>Suszynska</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kucia M"><surname>Kucia</surname> <given-names>M</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-106">Does it make sense to target one tumor cell chemotactic factor or its receptor when several chemotactic axes are involved in metastasis of the same cancer?</article-title> <source hwp:id="source-108">Clinical and translational medicine</source> <volume>5</volume>(<issue>1</issue>): <fpage>28</fpage>.</citation></ref><ref id="c109" hwp:id="ref-109" hwp:rev-id="xref-ref-109-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.109" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-109"><string-name name-style="western" hwp:sortable="Resnik N"><surname>Resnik</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Repnik U"><surname>Repnik</surname> <given-names>U</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kreft ME"><surname>Kreft</surname> <given-names>ME</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-107">Highly Selective Anti-Cancer Activity of Cholesterol-Interacting Agents Methyl-beta-Cyclodextrin and Ostreolysin A/Pleurotolysin B Protein Complex on Urothelial Cancer Cells</article-title>. <source hwp:id="source-109">PLoS One</source> <volume>10</volume>(<issue>9</issue>): <fpage>e0137878</fpage>.</citation></ref><ref id="c110" hwp:id="ref-110" hwp:rev-id="xref-ref-110-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.110" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-110"><string-name name-style="western" hwp:sortable="Ridgway ND"><surname>Ridgway</surname> <given-names>ND</given-names></string-name>, <string-name name-style="western" hwp:sortable="Byers DM"><surname>Byers</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cook HW"><surname>Cook</surname> <given-names>HW</given-names></string-name>, <etal>et al.</etal> (<year>1999</year>). <article-title hwp:id="article-title-108">Integration of phospholipid and sterol metabolism in mammalian cells</article-title>. <source hwp:id="source-110">Progress in Lipid Research</source> <volume>38</volume>(<issue>4</issue>): <fpage>337</fpage>–<lpage>60</lpage>.</citation></ref><ref id="c111" hwp:id="ref-111" hwp:rev-id="xref-ref-111-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.111" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-111"><string-name name-style="western" hwp:sortable="Ríos-Marco P"><surname>Ríos-Marco</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marco C"><surname>Marco</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gálvez X"><surname>Gálvez</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title hwp:id="article-title-109">Alkylphospholipids: An update on molecular mechanisms and clinical relevance</article-title>. <source hwp:id="source-111">Biochimica et Biophysica Acta (BBA) - Biomembranes</source>.</citation></ref><ref id="c112" hwp:id="ref-112" hwp:rev-id="xref-ref-112-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.112" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-112"><string-name name-style="western" hwp:sortable="Rojas K"><surname>Rojas</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stuckey A"><surname>Stuckey</surname> <given-names>A</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-110">Breast Cancer Epidemiology and Risk Factors</article-title>. <source hwp:id="source-112">Clin Obstet Gynecol</source> <volume>59</volume>(<issue>4</issue>):<fpage>651</fpage>–<lpage>72</lpage>.</citation></ref><ref id="c113" hwp:id="ref-113" hwp:rev-id="xref-ref-113-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.113" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-113"><string-name name-style="western" hwp:sortable="Roka E"><surname>Roka</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ujhelyi Z"><surname>Ujhelyi</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Deli M"><surname>Deli</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-111">Evaluation of the Cytotoxicity of alpha-Cyclodextrin Derivatives on the Caco-2 Cell Line and Human Erythrocytes</article-title>. <source hwp:id="source-113">Molecules</source> <volume>20</volume>(<issue>11</issue>): <fpage>20269</fpage>–<lpage>85</lpage>.</citation></ref><ref id="c114" hwp:id="ref-114" hwp:rev-id="xref-ref-114-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.114" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-114"><string-name name-style="western" hwp:sortable="Samie MA"><surname>Samie</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xu H"><surname>Xu</surname> <given-names>H</given-names></string-name> (<year>2014</year>). <article-title hwp:id="article-title-112">Lysosomal exocytosis and lipid storage disorders</article-title>. <source hwp:id="source-114">J Lipid Res</source> <volume>55</volume>(<issue>6</issue>): <fpage>995</fpage>–<lpage>1009</lpage>.</citation></ref><ref id="c115" hwp:id="ref-115" hwp:rev-id="xref-ref-115-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.115" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-115"><string-name name-style="western" hwp:sortable="Schneider G"><surname>Schneider</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sellers ZP"><surname>Sellers</surname> <given-names>ZP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Abdel-Latif A"><surname>Abdel-Latif</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-113">Bioactive lipids, LPC and LPA, are novel prometastatic factors and their tissue levels increase in response to radio/chemotherapy</article-title>. <source hwp:id="source-115">Mol Cancer Res</source> <volume>12</volume>(<issue>11</issue>): <fpage>1560</fpage>–<lpage>73</lpage>.</citation></ref><ref id="c116" hwp:id="ref-116" hwp:rev-id="xref-ref-116-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.116" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-116"><string-name name-style="western" hwp:sortable="Shiratori Y"><surname>Shiratori</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Okwu AK"><surname>Okwu</surname> <given-names>AK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tabas I"><surname>Tabas</surname> <given-names>I</given-names></string-name> (<year>1994</year>). <article-title hwp:id="article-title-114">Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and up-regulation of CTP: phosphocholine cytidylyltransferase</article-title>. <source hwp:id="source-116">J Biol Chem</source> <volume>269</volume>(<issue>15</issue>): <fpage>11337</fpage>–<lpage>48</lpage>.</citation></ref><ref id="c117" hwp:id="ref-117" hwp:rev-id="xref-ref-117-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.117" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-117"><string-name name-style="western" hwp:sortable="Shityakov S"><surname>Shityakov</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Salmas RE"><surname>Salmas</surname> <given-names>RE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Salvador E"><surname>Salvador</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-115">Evaluation of the potential toxicity of unmodified and modified cyclodextrins on murine blood-brain barrier endothelial cells</article-title>. <source hwp:id="source-117">J Toxicol Sci</source> <volume>41</volume>(<issue>2</issue>): <fpage>175</fpage>–<lpage>84</lpage>.</citation></ref><ref id="c118" hwp:id="ref-118" hwp:rev-id="xref-ref-118-1 xref-ref-118-2 xref-ref-118-3"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.118" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-118"><string-name name-style="western" hwp:sortable="Siddiq A"><surname>Siddiq</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Couch FJ"><surname>Couch</surname> <given-names>FJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen GK"><surname>Chen</surname> <given-names>GK</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-116">A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6 q14 and 20 q11</article-title>. <source hwp:id="source-118">Hum Mol Genet</source> <volume>21</volume>(<issue>24</issue>): <fpage>5373</fpage>–<lpage>84</lpage>.</citation></ref><ref id="c119" hwp:id="ref-119" hwp:rev-id="xref-ref-119-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.119" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-119"><string-name name-style="western" hwp:sortable="Siegel RL"><surname>Siegel</surname> <given-names>RL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Miller KD"><surname>Miller</surname> <given-names>KD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jemal A"><surname>Jemal</surname> <given-names>A</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-117">Cancer statistics</article-title>, 2016. <source hwp:id="source-119">CA: a cancer journal for clinicians</source> <volume>66</volume>(<issue>1</issue>): <fpage>7</fpage>–<lpage>30</lpage>.</citation></ref><ref id="c120" hwp:id="ref-120" hwp:rev-id="xref-ref-120-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.120" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-120"><string-name name-style="western" hwp:sortable="Singh A"><surname>Singh</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fedele C"><surname>Fedele</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lu H"><surname>Lu</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-118">Exosome-mediated Transfer of alphavbeta3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype</article-title>. <source hwp:id="source-120">Mol Cancer Res</source> <volume>14</volume>(<issue>11</issue>): <fpage>1136</fpage>–<lpage>46</lpage>.</citation></ref><ref id="c121" hwp:id="ref-121" hwp:rev-id="xref-ref-121-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.121" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-121"><string-name name-style="western" hwp:sortable="Snowden SG"><surname>Snowden</surname> <given-names>SG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Grapov D"><surname>Grapov</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Settergren M"><surname>Settergren</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-119">High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy</article-title>. <source hwp:id="source-121">Circ Cardiovasc Genet</source> <volume>7</volume>(<issue>6</issue>): <fpage>955</fpage>–<lpage>64</lpage>.</citation></ref><ref id="c122" hwp:id="ref-122" hwp:rev-id="xref-ref-122-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.122" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-122"><string-name name-style="western" hwp:sortable="Storch CH"><surname>Storch</surname> <given-names>CH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ehehalt R"><surname>Ehehalt</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Haefeli WE"><surname>Haefeli</surname> <given-names>WE</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title hwp:id="article-title-120">Localization of the human breast cancer resistance protein (BCRP/ABCG2) in lipid rafts/caveolae and modulation of its activity by cholesterol in vitro</article-title>. <source hwp:id="source-122">J Pharmacol Exp Ther</source> <volume>323</volume>(<issue>1</issue>): <fpage>257</fpage>–<lpage>64</lpage>.</citation></ref><ref id="c123" hwp:id="ref-123" hwp:rev-id="xref-ref-123-1 xref-ref-123-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.123" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-123"><string-name name-style="western" hwp:sortable="Takahashi S"><surname>Takahashi</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Homma K"><surname>Homma</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhou Y"><surname>Zhou</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-121">Susceptibility of outer hair cells to cholesterol chelator 2 -hydroxypropyl-beta-cyclodextrine is prestin-dependent</article-title>. <source hwp:id="source-123">Sci Rep</source> <volume>6</volume>: <fpage>21973</fpage>.</citation></ref><ref id="c124" hwp:id="ref-124" hwp:rev-id="xref-ref-124-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.124" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-124"><string-name name-style="western" hwp:sortable="Tomas A"><surname>Tomas</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Futter CE"><surname>Futter</surname> <given-names>CE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eden ER"><surname>Eden</surname> <given-names>ER</given-names></string-name> (<year>2014</year>). <article-title hwp:id="article-title-122">EGF receptor trafficking: consequences for signaling and cancer</article-title>. <source hwp:id="source-124">Trends Cell Biol</source> <volume>24</volume>(<issue>1</issue>): <fpage>26</fpage>–<lpage>34</lpage>.</citation></ref><ref id="c125" hwp:id="ref-125" hwp:rev-id="xref-ref-125-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.125" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-125"><string-name name-style="western" hwp:sortable="van Agthoven T"><surname>van Agthoven</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sieuwerts AM"><surname>Sieuwerts</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Veldscholte J"><surname>Veldscholte</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title hwp:id="article-title-123">CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer</article-title>. <source hwp:id="source-125">Br J Cancer</source> <volume>101</volume>(<issue>11</issue>): <fpage>1824</fpage>–<lpage>32</lpage>.</citation></ref><ref id="c126" hwp:id="ref-126" hwp:rev-id="xref-ref-126-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.126" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-126"><string-name name-style="western" hwp:sortable="Vance JE"><surname>Vance</surname> <given-names>JE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Karten B"><surname>Karten</surname> <given-names>B</given-names></string-name> (<year>2014</year>). <article-title hwp:id="article-title-124">Niemann-Pick C disease and mobilization of lysosomal cholesterol by cyclodextrin</article-title>. <source hwp:id="source-126">Journal of Lipid Research</source> <volume>55</volume>(<issue>8</issue>): <fpage>1609</fpage>–<lpage>21</lpage>.</citation></ref><ref id="c127" hwp:id="ref-127" hwp:rev-id="xref-ref-127-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.127" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-127"><string-name name-style="western" hwp:sortable="Varticovski L"><surname>Varticovski</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Daley GQ"><surname>Daley</surname> <given-names>GQ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jackson P"><surname>Jackson</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> (<year>1991</year>). <article-title hwp:id="article-title-125">Activation of phosphatidylinositol 3 -kinase in cells expressing abl oncogene variants</article-title>. <source hwp:id="source-127">Mol Cell Biol</source> <volume>11</volume>(<issue>2</issue>): <fpage>1107</fpage>–<lpage>13</lpage>.</citation></ref><ref id="c128" hwp:id="ref-128" hwp:rev-id="xref-ref-128-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.128" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-128"><string-name name-style="western" hwp:sortable="Viaud J"><surname>Viaud</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mansour R"><surname>Mansour</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Antkowiak A"><surname>Antkowiak</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-126">Phosphoinositides: Important lipids in the coordination of cell dynamics</article-title>. <source hwp:id="source-128">Biochimie</source> <volume>125</volume>: <fpage>250</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c129" hwp:id="ref-129" hwp:rev-id="xref-ref-129-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.129" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-129"><string-name name-style="western" hwp:sortable="Vite CH"><surname>Vite</surname> <given-names>CH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bagel JH"><surname>Bagel</surname> <given-names>JH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Swain GP"><surname>Swain</surname> <given-names>GP</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-127">Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease</article-title>. <source hwp:id="source-129">Sci Transl Med</source> <volume>7</volume>(<issue>276</issue>): <fpage>276</fpage> ra26.</citation></ref><ref id="c130" hwp:id="ref-130" hwp:rev-id="xref-ref-130-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.130" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-130"><string-name name-style="western" hwp:sortable="Wang CY"><surname>Wang</surname> <given-names>CY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lai MD"><surname>Lai</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Phan NN"><surname>Phan</surname> <given-names>NN</given-names></string-name>, <etal>et al.</etal> (<year>2015a</year>). <article-title hwp:id="article-title-128">Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients</article-title>. <source hwp:id="source-130">PLoS One</source> <volume>10</volume>(<issue>7</issue>): <fpage>e0125766</fpage>.</citation></ref><ref id="c131" hwp:id="ref-131" hwp:rev-id="xref-ref-131-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.131" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-131"><string-name name-style="western" hwp:sortable="Wang J"><surname>Wang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sun Y"><surname>Sun</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Qu J"><surname>Qu</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title hwp:id="article-title-129">Roles of LPA receptor signaling in breast cancer</article-title>. <source hwp:id="source-131">Expert review of molecular diagnostics</source> <volume>16</volume>(<issue>10</issue>): <fpage>1103</fpage>–<lpage>11</lpage>.</citation></ref><ref id="c132" hwp:id="ref-132" hwp:rev-id="xref-ref-132-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.132" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-132"><string-name name-style="western" hwp:sortable="Wang SJ"><surname>Wang</surname> <given-names>SJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cui HY"><surname>Cui</surname> <given-names>HY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu YM"><surname>Liu</surname> <given-names>YM</given-names></string-name>, <etal>et al.</etal> (<year>2015b</year>). <article-title hwp:id="article-title-130">CD147 promotes Src-dependent activation of Rac1 signaling through STAT3/DOCK8 during the motility of hepatocellular carcinoma cells</article-title>. <source hwp:id="source-132">Oncotarget</source> <volume>6</volume>(<issue>1</issue>): <fpage>243</fpage>–<lpage>57</lpage>.</citation></ref><ref id="c133" hwp:id="ref-133" hwp:rev-id="xref-ref-133-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.133" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-133"><string-name name-style="western" hwp:sortable="Ward S"><surname>Ward</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="O'Donnell P"><surname>O'Donnell</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fernandez S"><surname>Fernandez</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title hwp:id="article-title-131">2 -hydroxypropyl-beta-cyclodextrin raises hearing threshold in normal cats and in cats with Niemann-Pick type C disease</article-title>. <source hwp:id="source-133">Pediatr Res</source> <volume>68</volume>(<issue>1</issue>): <fpage>52</fpage>–<lpage>6</lpage>.</citation></ref><ref id="c134" hwp:id="ref-134" hwp:rev-id="xref-ref-134-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.134" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-134"><string-name name-style="western" hwp:sortable="Watson CA"><surname>Watson</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vine KL"><surname>Vine</surname> <given-names>KL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Locke JM"><surname>Locke</surname> <given-names>JM</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title hwp:id="article-title-132">The antiangiogenic properties of sulfated beta-cyclodextrins in anticancer formulations incorporating 5 -fluorouracil</article-title>. <source hwp:id="source-134">Anti-cancer drugs</source> <volume>24</volume>(<issue>7</issue>): <fpage>704</fpage>–<lpage>14</lpage>.</citation></ref><ref id="c135" hwp:id="ref-135" hwp:rev-id="xref-ref-135-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.135" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-135"><string-name name-style="western" hwp:sortable="Wen Y"><surname>Wen</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alshikho MJ"><surname>Alshikho</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Herbert MR"><surname>Herbert</surname> <given-names>MR</given-names></string-name> (<year>2016</year>). <article-title hwp:id="article-title-133">Pathway Network Analyses for Autism Reveal Multisystem Involvement, Major Overlaps with Other Diseases and Convergence upon MAPK and Calcium Signaling</article-title>. <source hwp:id="source-135">PLoS One</source> <volume>11</volume>(<issue>4</issue>): <fpage>e0153329</fpage>.</citation></ref><ref id="c136" hwp:id="ref-136" hwp:rev-id="xref-ref-136-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.136" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-136"><string-name name-style="western" hwp:sortable="Wilcoxon F"><surname>Wilcoxon</surname> <given-names>F</given-names></string-name> (<year>1954</year>). <article-title hwp:id="article-title-134">Individual comparisons by ranking methods</article-title>. <source hwp:id="source-136">Biometrics</source> <volume>1</volume>: <fpage>80</fpage>–<lpage>3</lpage>.</citation></ref><ref id="c137" hwp:id="ref-137" hwp:rev-id="xref-ref-137-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.137" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-137"><string-name name-style="western" hwp:sortable="Wilson PM"><surname>Wilson</surname> <given-names>PM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fryer RH"><surname>Fryer</surname> <given-names>RH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fang Y"><surname>Fang</surname> <given-names>Y</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title hwp:id="article-title-135">Astn2, A Novel Member of the Astrotactin Gene Family,Regulates the Trafficking of ASTN1 during Glial-Guided Neuronal Migration</article-title>. <source hwp:id="source-137">The Journal of Neuroscience</source> <volume>30</volume>(<issue>25</issue>): <fpage>8529</fpage>–<lpage>40</lpage>.</citation></ref><ref id="c138" hwp:id="ref-138" hwp:rev-id="xref-ref-138-1 xref-ref-138-2 xref-ref-138-3 xref-ref-138-4 xref-ref-138-5 xref-ref-138-6 xref-ref-138-7 xref-ref-138-8 xref-ref-138-9"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.138" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-138"><string-name name-style="western" hwp:sortable="Wittkowski KM"><surname>Wittkowski</surname> <given-names>KM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sonakya V"><surname>Sonakya</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bigio B"><surname>Bigio</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-136">A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism</article-title>. <source hwp:id="source-138">Transl Psychiatry</source> <volume>4</volume>: <fpage>e354</fpage>.</citation></ref><ref id="c139" hwp:id="ref-139" hwp:rev-id="xref-ref-139-1 xref-ref-139-2 xref-ref-139-3 xref-ref-139-4"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.139" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-139"><string-name name-style="western" hwp:sortable="Wittkowski KM"><surname>Wittkowski</surname> <given-names>KM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sonakya V"><surname>Sonakya</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Song T"><surname>Song</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> (<year>2013</year>). <article-title hwp:id="article-title-137">From single-SNP to wide-locus: genome-wide association studies identifying functionally related genes and intragenic regions in small sample studies</article-title>. <source hwp:id="source-139">Pharmacogenomics</source> <volume>14</volume>(<issue>4</issue>): <fpage>391</fpage>–<lpage>401</lpage>.</citation></ref><ref id="c140" hwp:id="ref-140" hwp:rev-id="xref-ref-140-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.140" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-140"><string-name name-style="western" hwp:sortable="Wittkowski KM"><surname>Wittkowski</surname> <given-names>KM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Song T"><surname>Song</surname> <given-names>T</given-names></string-name> (<year>2010</year>). <article-title hwp:id="article-title-138">Nonparametric methods for molecular biology</article-title>. <source hwp:id="source-140">Methods Mol Biol</source> <volume>620</volume>: <fpage>105</fpage>–<lpage>53</lpage>.</citation></ref><ref id="c141" hwp:id="ref-141" hwp:rev-id="xref-ref-141-1"><citation publication-type="website" citation-type="web" ref:id="152405v2.141" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-141"><string-name name-style="western" hwp:sortable="Wittkowski KM"><surname>Wittkowski</surname> <given-names>KM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Song T."><surname>Song</surname> <given-names>T.</given-names></string-name> (<year>2012</year>). <source hwp:id="source-141">muStat. from</source> <ext-link l:rel="related" l:ref-type="uri" l:ref="https://CRAN.R-project.org/package=muStat" ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=muStat" hwp:id="ext-link-6">https://CRAN.R-project.org/package=muStat</ext-link>.</citation></ref><ref id="c142" hwp:id="ref-142" hwp:rev-id="xref-ref-142-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.142" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-142"><string-name name-style="western" hwp:sortable="Woolley JF"><surname>Woolley</surname> <given-names>JF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dzneladze I"><surname>Dzneladze</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Salmena L"><surname>Salmena</surname> <given-names>L</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-139">Phosphoinositide signaling in cancer: INPP4B Akt(s) out</article-title>. <source hwp:id="source-142">Trends Mol Med</source> <volume>21</volume>(<issue>9</issue>): <fpage>530</fpage>–<lpage>2</lpage>.</citation></ref><ref id="c143" hwp:id="ref-143" hwp:rev-id="xref-ref-143-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.143" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-143"><string-name name-style="western" hwp:sortable="Wu MC"><surname>Wu</surname> <given-names>MC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kraft P"><surname>Kraft</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Epstein MP"><surname>Epstein</surname> <given-names>MP</given-names></string-name>, <etal>et al.</etal> (<year>2010b</year>). <article-title hwp:id="article-title-140">Powerful SNP-set analysis for case-control genome-wide association studies</article-title>. <source hwp:id="source-143">Am J Hum Genet</source> <volume>86</volume>(<issue>6</issue>): <fpage>929</fpage>–<lpage>42</lpage>.</citation></ref><ref id="c144" hwp:id="ref-144" hwp:rev-id="xref-ref-144-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.144" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-144"><string-name name-style="western" hwp:sortable="Yamaguchi H"><surname>Yamaguchi</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Takeo Y"><surname>Takeo</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yoshida S"><surname>Yoshida</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title hwp:id="article-title-141">Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells</article-title>. <source hwp:id="source-144">Cancer Res</source> <volume>69</volume>(<issue>22</issue>): <fpage>8594</fpage>–<lpage>602</lpage>.</citation></ref><ref id="c145" hwp:id="ref-145" hwp:rev-id="xref-ref-145-1 xref-ref-145-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.145" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-145"><string-name name-style="western" hwp:sortable="Yamaguchi R"><surname>Yamaguchi</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Perkins G"><surname>Perkins</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hirota K"><surname>Hirota</surname> <given-names>K</given-names></string-name> (<year>2015</year>). <article-title hwp:id="article-title-142">Targeting cholesterol with beta-cyclodextrin sensitizes cancer cells for apoptosis</article-title>. <source hwp:id="source-145">FEBS Lett</source> <volume>589</volume>(<issue>24 Pt B</issue>): <fpage>4097</fpage>–<lpage>105</lpage>.</citation></ref><ref id="c146" hwp:id="ref-146" hwp:rev-id="xref-ref-146-1 xref-ref-146-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.146" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-146"><string-name name-style="western" hwp:sortable="Yamashita T"><surname>Yamashita</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hakizimana P"><surname>Hakizimana</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu S"><surname>Wu</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-143">Outer Hair Cell Lateral Wall Structure Constrains the Mobility of Plasma Membrane Proteins</article-title>. <source hwp:id="source-146">PLoS Genet</source> <volume>11</volume>(<issue>9</issue>): <fpage>e1005500</fpage>.</citation></ref><ref id="c147" hwp:id="ref-147" hwp:rev-id="xref-ref-147-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.147" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-147"><string-name name-style="western" hwp:sortable="Yan H"><surname>Yan</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhu S"><surname>Zhu</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Song C"><surname>Song</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title hwp:id="article-title-144">Bone morphogenetic protein (BMP) signaling regulates mitotic checkpoint protein levels in human breast cancer cells</article-title>. <source hwp:id="source-147">Cell Signal</source> <volume>24</volume>(<issue>4</issue>): <fpage>961</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c148" hwp:id="ref-148" hwp:rev-id="xref-ref-148-1 xref-ref-148-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.148" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-148"><string-name name-style="western" hwp:sortable="Yokoo M"><surname>Yokoo</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kubota Y"><surname>Kubota</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Motoyama K"><surname>Motoyama</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title hwp:id="article-title-145">2 -Hydroxypropyl-beta-Cyclodextrin Acts as a Novel Anticancer Agent</article-title>. <source hwp:id="source-148">PLoS One</source> <volume>10</volume>(<issue>11</issue>): <fpage>e0141946</fpage>.</citation></ref><ref id="c149" hwp:id="ref-149" hwp:rev-id="xref-ref-149-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.149" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-149"><string-name name-style="western" hwp:sortable="Zafar A"><surname>Zafar</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu F"><surname>Wu</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hardy K"><surname>Hardy</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> (<year>2014</year>). <article-title hwp:id="article-title-146">Chromatinized protein kinase C-theta directly regulates inducible genes in epithelial to mesenchymal transition and breast cancer stem cells</article-title>. <source hwp:id="source-149">Mol Cell Biol</source> <volume>34</volume>(<issue>16</issue>): <fpage>2961</fpage>–<lpage>80</lpage>.</citation></ref><ref id="c150" hwp:id="ref-150" hwp:rev-id="xref-ref-150-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.150" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-150"><string-name name-style="western" hwp:sortable="Zhang L"><surname>Zhang</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gong C"><surname>Gong</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lau SL"><surname>Lau</surname> <given-names>SL</given-names></string-name>, <etal>et al.</etal> (<year>2013b</year>). <article-title hwp:id="article-title-147">SpliceArray profiling of breast cancer reveals a novel variant of NCOR2/SMRT that is associated with tamoxifen resistance and control of ERalpha transcriptional activity</article-title>. <source hwp:id="source-150">Cancer Res</source> <volume>73</volume>(<issue>1</issue>): <fpage>246</fpage>–<lpage>55</lpage>.</citation></ref><ref id="c151" hwp:id="ref-151" hwp:rev-id="xref-ref-151-1"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.151" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-151"><string-name name-style="western" hwp:sortable="Zhang L"><surname>Zhang</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang S"><surname>Zhang</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yao J"><surname>Yao</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> (<year>2015a</year>). <article-title hwp:id="article-title-148">Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth</article-title>. <source hwp:id="source-151">Nature</source> <volume>527</volume>(<issue>7576</issue>): <fpage>100</fpage>–<lpage>4</lpage>.</citation></ref><ref id="c152" hwp:id="ref-152" hwp:rev-id="xref-ref-152-1 xref-ref-152-2"><citation publication-type="journal" citation-type="journal" ref:id="152405v2.152" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-152"><string-name name-style="western" hwp:sortable="Zhang Q"><surname>Zhang</surname> <given-names>Q</given-names></string-name>, <string-name name-style="western" hwp:sortable="Furukawa K"><surname>Furukawa</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen HH"><surname>Chen</surname> <given-names>HH</given-names></string-name>, <etal>et al.</etal> (<year>2006</year>). <article-title hwp:id="article-title-149">Metastatic potential of mouse Lewis lung cancer cells is regulated via ganglioside GM1 by modulating the matrix metalloprotease-9 localization in lipid rafts</article-title>. <source hwp:id="source-152">J Biol Chem</source> <volume>281</volume>(<issue>26</issue>): <fpage>18145</fpage>–<lpage>55</lpage>.</citation></ref></ref-list></back></article>
